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Abstract
Diverse interactions between soft tissues and implanted biomaterials directly influence
the success or failure of therapeutic interventions. The nature and extent of these
interactions strongly depend on both the tissue and material in question and can
presumably be characterized for any given clinical application. Nevertheless, optimizing
biomaterial performance remains a challenge in many implant scenarios due to complex
relationships between intrinsic material properties and tissue response. Soft tissue
sealants are clinically-relevant biomaterials which impart therapeutic benefit through
adhesion to tissue, thus exhibiting a direct functional dependence on tissue-material
reactivity. Because adhesion can be rigorously quantified and correlated to the local
tissue response, sealants provide an informative platform for studying material
properties, soft tissues, and their interplay. We developed a model hydrogel sealant
composed of aminated polyethylene glycol and dextran aldehyde (PEG:dextran) that
can possess a wide range of bulk and adhesive properties by virtue of constituent
polymer modifications. Through comparison to traditional sealants, we established that
highly viscoelastic adhesion promotes tissue-sealant interfacial failure resistance
without compromising underlying tissue morphology. We analyzed multiple soft tissues
to substantiate the notion that natural biochemical variability facilitates the design of
tissue-specific sealants which have distinct advantages over more general alternatives.
We confirmed that hydrogel-based materials are an attractive material class for
ensuring sealant biocompatibility, but found that a marked reduction in adhesive
strength following characteristic swell can potentially limit clinical efficacy. To mitigate
the swell-induced loss of hydrogel-based sealant functionality, a biomimetic conjugation
strategy derived from marine mussel adhesion was applied to PEG:dextran and shown
to favorably modulate adhesion. In all phases of this research, we defined material
design principles that extend beyond the immediate development of PEG:dextran with
potential to enhance the clinical performance of a range of biomaterials.
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1. Introduction
1.1 PROJECT OVERVIEW
Interactions between tissues and materials are of paramount importance in
determining the overall efficacy of implanted medical devices [1-3]. These interactions
happen on various timescales, with both local tissues and implanted materials often
undergoing significant property changes throughout the course of therapeutic treatment.
The nature of relevant property changes differs among clinical applications, and can
range from an instant instigation of blood clotting to the chronic evolution of a stiff
fibrotic capsule around an initially flexible implant [4, 5]. In all cases, the dynamic
interplay between tissues and materials will determine both the duration and extent of
therapeutic benefit to the patient. In this thesis, focus is directed towards the study of
tissue-material interactions operative with application of soft tissue sealants. These
degradable implants are characterized by a functional dependence on material
bioreactivity, motivating an in-depth analysis of soft tissue-adhesive material
interactions.
Soft tissue sealants are used in surgery as a means to attain homeostasis, prevent
anastomotic leakage, and provide mechanical support to healing tissues [6-8]. Particular
sealant applications include repair of internal lacerations, filling of void spaces after
tissue resection, and suture-line reinforcement to prevent tissue dehiscence [9-12].
Although clinical outcomes following the use of current sealants are generally
acceptable, available materials are classically limited by a lack of adhesion strength
and/or tissue insult upon adherence [13-15]. Commercial fibrin sealants lose adhesion
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to tissue shortly after implantation and exhibit a dangerous tendency to pool bacteria
and biologic debris at a wound site [16, 17]. More chemically reactive sealants, such as
polycyanoacrylate derivatives, are also available and provide superior adhesion
strength. However, in vivo data suggest that the cost of prolonged adhesion with these
materials includes tissue ischemia, inflammation, and undesirable peritoneal adhesion
formation. Previous studies have even reported a significant inhibition of cellular
proliferation when fibroblasts are indirectly exposed to polycyanoacrylates in an elution
test system [18, 19].
In this work we seek methods of controlling tissue-material interactions to yield high
strength adhesion without excessive tissue insult. We employ a canonical class of
biochemistry to direct tissue-material adhesion, namely aldehyde-amine covalent
bonding. We analyze tissue-material interactions in experimental frameworks which
consider practical issues such as adhesive mechanics, tissue inflammation, tissue-
specific adhesion, and functionally deterministic property changes following
implantation. The goal of this work is to better understand tissue-material interactions in
the context of bioadhesive sealants, and to generalize the resulting concepts to the
design and development of other implanted biomaterials.
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Basic sealant properties
Multiple properties are required to qualify a material as a potential soft tissue sealant
[20]. Primarily, the material must be capable of adhesion to soft tissues under
physiologic conditions. In order to justify clinical use, a sealant must remain at the
application surface for a given period of time throughout which some therapeutic benefit
(i.e. mechanical support, leakage prevention, or localized drug delivery) is conferred to
underlying tissue. The material must be biodegradable or bioeliminable, such that upon
implant clearance local tissues can complete regeneration or repair processes. The
material must be usable in the surgical setting, generally requiring a phase transition
from a low viscosity liquid during administration into a solid or gel-like material in situ. A
material which satisfies the above properties may well function as a clinically effective
sealant, although attempts with a wide range of candidate adhesives have yielded
limited success.
State of the art
Materials which adhere to soft tissues typically exhibit a limiting tradeoff between
adhesion strength and biocompatibility (Figure 1). Canonical soft tissue sealants
represent opposite ends of this property spectrum, as fibrin glues (FG) and
cyanoacrylate derivatives (CA) are functionally bounded by insufficient adhesion
strength or poor biocompatibility, respectively [13-15]. FG achieve adherence via Factor
Xllla-mediated covalent bond formation between constituent fibrin polymer and tissue
collagen in a process analogous to natural blood coagulation (Figure 2). CA derivatives
achieve adherence via on-site anionic polymerization in response to tissue-present
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hydroxyl ions or weak-base proteins (Figure 3). Highly reactive CA-based materials
densely crosslink tissue and as a result display high strength adhesion, but in doing so
deform native morphology, incite tissue inflammation, and induce cytotoxicity upon
degradation and release of typically small crosslinking molecules (such as
formaldehyde). Less reactive FG achieve comparatively sparse tissue crosslinking and
as a result adhere weakly, but generally cause minimal tissue inflammation or
deformation. Despite significant compositional variance between available soft tissue
sealants, no adhesive material fully meets clinical demands.
Figure 1 Schematic representation of the tradeoffs associated with use of currently available soft
tissue sealants. Canonical materials generally are limited by suboptimal adhesion strength or
biocompatibility.
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Figure 2 Schematic representation of the crosslinking mechanism employed by fibrin glues.
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Figure 3 Schematic representation of the crosslinking mechanism employed by cyanoacrylate-
based sealants.
It is clear that functional material adherence to tissue requires rapid, on-site sealant
polymerization and integrative bond formation with tissue-present moieties. Ultimate
sealant efficacy is understood as a function of adhesion strength, bulk material
properties, material degradation kinetics, local tissue response, and the biocompatibility
of by-products evolved throughout material clearance. These deterministic properties
are likely correlated due to a common dependence on the extent and nature of tissue-
material interactions.
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1.2 CLINICAL MOTIVATION
Small bowel resection (Figure 4) is a common medical procedure for treating
numerous diseases of the gastrointestinal tract [21-24]. Clinical instances of intestinal
obstruction or inflammation requiring resection can stem from a variety of conditions,
including scar tissue formation, trauma, tissue deformities, gastrointestinal stromal
tumors (GIST), and Crohn's Disease (Figure 5). Following tissue excision, the created
ends of the small intestine are typically reconnected via staples or sutures. Such
methodology is generally successful, but post-operative complications are reported in
approximately 15% of procedures [25-27]. Risk factors of resection procedures include
bleeding, infection, and leakage from the anastomotic site, all which arise primarily from
incomplete closure or healing of the surrounding tissue. Modification of the anastomotic
site to enhance integrity and promote healing is a logical approach to reduce the
occurrence of intestinal dehiscence and associated risk factors. Adhesive sealants
could improve intestinal healing if used in conjunction with standard closure techniques.
The potential benefits of anastomotic augmentation justify small bowel resection as a
clinical model for study of adhesive sealants.
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Figure 4 Pictorial description of small
reattached with sutures or staples [28].
bowel resection. Following resection, healthy tissue is
Figure 5 Endoscopic image of ulcer prevalent
Crohn's disease. In some cases, recurrent
numerous ulcers must be surgically removed
tissue resection [29].
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Additional clinical sealant applications motivate the examination of interactions
between adhesive materials and various soft tissues. Resection procedures are
routinely conducted to remove diseased or dysfunctional soft tissue, including
pulmonary, hepatic, and cardiac tissues [30-33]. In these and other similar operations,
tissue sealants can provide a means of quickly attaining hemostasis and further provide
a temporary scaffold to enhance surgical wound healing. Despite such an array of
applications, differences between tissue propensities for adherence have not been
explicitly considered in sealant design. Because the adhesive strength of a surgical
sealant is derived from bonding to apposed tissue, interfacial properties and ultimately
sealant performance are expected to depend on the chemistries of both the tissue and
material. We expect that consideration of target tissue bed reactivity in application-
specific adhesive design can lead to increasingly biocompatible and efficacious clinical
sealants.
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1.3 SCOPE
The use of biomaterial implants has been noted throughout ancient history, with
documented examples occurring an astonishing 32,000 years ago [34]. Today,
countless clinical applications feature biomaterials integrated into medical devices or
implants, and many others use such materials in isolation. About 60 years ago it was
recognized that the interactions between biomaterials and surrounding tissues largely
determine the ultimate success or failure of a particular intervention, spurring a
movement to design increasingly biocompatible materials [1, 34].
A major challenge of biomaterials engineering is first defining and second fulfilling
the emergent requirement of biocompatibility for a given clinical application. A material
cannot be accurately designated as 'biocompatible' in any general sense. Instead,
biocompatibility must be based on "the ability of a material to perform with an
appropriate host response in a specific situation [1]." Biocompatibility and biomaterial
efficacy can only be assessed with a unified understanding of material properties, tissue
response, and therapeutic intent.
As stated above, this thesis is a study of tissue-material interactions in the context of
soft tissue adhesive sealants. The universal challenge of engineering material
biocompatibility underlies this work, while limitations of soft tissue sealants focus the
scope of study. We pose following questions, which if answered will further the
understanding of tissue-material interactions and potentially lead to the design of a
superior soft tissue sealant.
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1. Can aldehyde-mediated chemistry provide a platform for attaining rapid and directed
adhesion between tissue and material?
2. Is there a relationship between constitutive descriptors of adhesive interfacial
mechanics and metrics of sealant performance?
3. Can viscoelastic relaxation of interfacial stress be exploited as design strategy for
minimally reactive yet efficacious soft tissue sealants?
4. Do all soft tissues interact similarly with adhesive materials, or does biochemical
variation facilitate tissue-specific sealant design for optimal clinical performance?
5. Do the adhesive properties of a hydrogel sealant significantly diminish with hydration
state? If so, can a hydrogel adhesive be chemically modified to prevent property loss
upon swell?
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2. Outline
2.1 THESIS STATEMENT
Tissue-material interactions are influenced by the chemical and physical properties
of the tissue as well as the material. Biomaterial adhesion to soft tissues should
therefore be sensitive to tissue type, enabling rational design, choice and evaluation of
therapeutic sealants. Bioadhesive materials provide a clinically-relevant and informative
platform to study tissue-material interactions. In particular, these implants have a
functional dependence on reaction with tissue, are formulated reproducibly with a full
spectrum of physical and chemical properties, and can be assessed in a quantifiable
and rigorous fashion. Bioadhesion is amenable to study via a variety of techniques,
including mechanical testing, mechanical modeling, quantitative microscopy, ex vivo
tissue experiments, and subcutaneous implantation studies. Employing a diverse set of
methodology and correlating resultant data should shed mechanistic insight into tissue-
material interactions and ultimately provide guidelines for design, evaluation and use of
advanced surgical sealants and other implantable biomaterials which interact with soft
tissue.
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2.2 HYPOTHESES
1. Aldehyde-amine chemistry can provide a means by which to control material
cohesion and tissue-material adhesion as amines within the materials control the
former and amines within the tissues determine the latter.
a. Soft tissue beds present different densities of target reactive sites for
aldehyde-mediated adhesion (amines) enabling tissue-specific formulations of
an optimal sealant.
2. High molecular weight hydrogel adhesives can preserve native tissue mechanics
and as a consequence induce minimal disturbance to local tissue structure under
physiologic loading conditions if their tissue crosslinking is controlled and molecular
mobility maintained.
a. The density of tissue-material crosslinks as well as the bulk material
mechanics together will determine the extent to which underlying tissue
mechanics are altered with sealant application.
b. High molecular weight hydrogel polymers in the hydrated state will retain
significant molecular mobility and better approximate tissue composition (as
compared to stiff, hydrophobic, high strength adhesives with low molecular
weight crosslinking) such that destructive interfacial stress concentrations are
minimized.
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3. Sealant swelling, although desirable for harmonizing tissue-material properties, will
notably diminish sealant performance as a consequence of passive interfacial
deformation.
a. Sealant swell occurring subsequent to the formation of a thin adhesive
interface will displace the material from tissue due to an asymmetric
expansion of the highly hydrophilic material with respect to stable tissue
geometry. This displacement represents an important form of intrinsic stress
which will amplify physiologic forces opposing tissue-material adhesion.
b. If deemed excessive, the adhesive loss of a hydrogel sealant upon swell can
be mitigated through a biomimetic approach based on the wet adhesion
mechanisms exhibited by marine animals.
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2.3 SPECIFIC AIMS
The specific aims of this thesis fall into two main categories, specifically controlling
biomaterial-tissue adhesion and understanding the effects of hydration on hydrogel-
mediated bioadhesion. The following specific aims are designated to test the stated
hypotheses.
Control of adhesion
1. Formulate and characterize an adhesive material system which features high
molecular weight aldehydes as the primary reactive constituent for interaction with
soft tissues.
2. Characterize the surface chemistry of various soft tissues with respect to
susceptibility for aldehyde-mediated adhesion. Rate tissue-bed modulation of
adhesive interactions.
3. Model the resultant mechanics following material adhesion to soft tissue and
correlate mechanical properties to metrics of sealant performance.
4. Relate adhesive mechanics to material and tissue properties.
Effects of hydration
5. Determine the extent of adhesive property loss of a hydrogel sealant as a function of
hydration.
6. Conjugate a biomimetic constituent to the hydrogel network in an effort to
recapitulate the wet adhesion exhibited by marine animals.
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3. Experimental Studies
3.1 STUDY 1 CHARACTERIZATION OF A MODEL SOFT TISSUE SEALANT
Publication disclosure
The following presentation of Study 1 is based on:
Characterization of star adhesive sealants based on PEG/Dextran hydrogels.
Artzi N, Shazly T, Crespo C, Ramos AB, Chenault HK, Edelman ER.
Macromol Biosci. 2009 Apr 21.
AND
Property Determinants of Dextran:Polyethylene Glycol Adhesive Sealants.
Shazly T., MS Thesis, MIT, Department of Material Science and Engineering, 2007
3.1.1 Abstract
A novel class of bioreactive hydrogels composed of aminated polyethylene glycol
(PEG) and dextran aldehyde polymers (PEG:dextran) are proposed as candidate soft
tissue sealants with potential to improve upon the performance of currently used
materials. Multiple compositional variations are available for both the PEG and dextran
constituent polymers, thus providing a family of PEG:dextran that is ideal for selectively
probing tissue-material interactions and informing iterative sealant design. Key material
properties determining sealant efficacy include swelling and degradation kinetics, elastic
modulus, bioadhesion strength, and biocompatibility. Relationships between these
pertinent properties and available compositional variations are determined for
PEG:dextran. A series of complementary studies reveal the following determinants of
material properties in PEG:dextran: constituent PEG amine molecular complexity
dictates hydrogel swell and stability in aqueous medium, PEG amine solid content
dictates hydrogel stiffness, available dextran aldehyde groups dictate adhesion
strength, and total material solid content and reactive group ratio dictate the cellular
response. Knowledge of functional property determinants facilitates design of
PEG:dextran for high strength, biocompatible adhesion to soft tissue, and enables the
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use of these materials to selectively study various aspects of tissue-material
interactions.
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3.1.2 Introduction
Internal surgical intervention necessitates the intentional wounding of soft tissue. In
many clinical procedures, soft tissue healing is dependent on established wound
closure techniques, such as suturing or stapling of disjoined tissues. Risk factors
associated with these techniques are largely attributed to the discrete nature of
interfacing with tissue, often inducing deleterious stress concentrations in healing
tissues and compromising wound site integrity [35, 36]. Clinical adhesive sealants are
biomaterials which can mitigate these risks by forming a continuous layer to stabilize
tissues and provide a temporary scaffold to support healing processes [6, 9, 37, 38].
However, available sealants present additional risk factors, are restricted in surgical
use, and have a clinical failure rate of approximately 15 % [25-27].
Commercially available sealants are generally limited by inadequate adhesion
strength or unacceptable local tissue response [13, 39-41]. Although fibrin glues are
considered biocompatible for most internal applications, they exhibit low strength
bioadhesion and quickly lose sealant functionality under physiologic loads. Alternatively,
cyanoacrylate-based polymers are high strength bioadhesives, but are cytotoxic, induce
inflammation, and can deform native soft tissue morphology; due to their lack of
biocompatibility, these materials are now primarily reserved for dermal applications. A
clear need exists for a high strength, biocompatible adhesive materials for application to
the full range of soft tissues.
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Aldehydes are classic reactive groups for tissue fixation and have been proposed as
primary bioreactive constituents in experimental adhesive sealants [42-44]. When
imbedded within a polymer network, aldehyde groups presented on short carbon
backbones (glutaraldehyde and formaldehyde) highly crosslink tissue, but upon material
degradation are cytotoxic, penetrate deep within tissues, and incite a significant
inflammatory response. Here we integrate a high molecular weight aldehyde (10 - 60
kDa) as the primary bioreactive constituent in an adhesive hydrogel. We intuit that the
toxicity following aldehyde-tissue interactions will be minimal if the aldehydes are
mounted on higher molecular weight materials such as dextran, a natural polymer of
glucose residues.
We demonstrate that when dextran aldehydes are crosslinked with an aminated
polyethylene glycol, spontaneous formation of a bioadhesive gel (PEG:dextran) occurs
via Schiff base reaction between constituent polymers. We synthesized and
characterized a family of PEG:dextran materials and found that network properties are
most responsive to variations in the PEG component (molecular structure and solid
content), while tissue-material adhesion and cellular response are aldehyde-mediated.
The established property determinants for PEG:dextran enables the design high
strength yet biocompatible materials and hints at a potential for tissue- and application-
specific formulations.
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3.1.3 Materials and Methods
PEG:dextran hydroaels
A novel material system is developed and utilized throughout this work to investigate
soft tissue-adhesive material interactions. The material under study is a bioadhesive
hydrogel which was pioneered by DuPont and has since emerged as a candidate
sealant with potential to address clinical needs [45, 46]. The Edelman Lab has
collaborated with DuPont on a number of research initiatives within the context of the
DuPont-MIT Alliance (DMA). DMA endeavors have resulted in both the elucidation of
scientific principles underlying clinically-relevant tissue-material interactions and the
advancement of a range of biotechnologies.
The novel adhesive hydrogel system features polyethylene glycol (PEG) and dextran
polymers which are functionalized to promote both cohesive network formation and
adhesive bonding to tissue. Solutions of an amine-modified PEG are prepared with
either linear or star-shaped polymers with molecular weights of 2 or 10 kDa. The linear
PEG has two amine groups per molecule which are tethered to each end, while the star
PEG consists of eight PEG chains joined at the center of a complex macromolecule with
an amine end group on each arm (Figure 6). The second hydrogel component is oxidized
dextran with reactive aldehyde side-groups present throughout the entire polymer chain
(Figure 7). The extent of oxidation is determined by the dextran molecular weight (10 - 60
kDa) and the relative amount of sodium periodate with which it is reacted. A calculable
number of aldehyde groups will be available after the dextran oxidation step and will
spontaneously react with the amines of PEG when the two components are mixed [47].
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Aldehyde groups which remain free following network formation will potentially facilitate
bioadhesion, as previous studies have indicated that oxidized dextran readily reacts
with soft tissues [48, 49].
Molecular structure of eight arm PEG
NalO 4
Dextran dehyde
Figure 7 Oxidation of dextran polymer with sodium periodate yields dextran
aldehyde.
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PEG and dextran constituents are separately prepared as aqueous solutions with
low viscosities to ensure practical sealant delivery. The highest solid content formulated
for either component (60 wt.%) has low enough viscosity to allow for easy injection
through a 5 ml syringe and a 20-gauge needle at room temperature. Prior to
polymerization, equal volumes of material components are loaded into separate
chambers of a dual-chamber syringe. A 12-step mixing tip is attached to the syringe as
a means to promote repeatable and extensive mixing of the two components (Figure 8).
Following mixed injection, the dextran aldehyde and aminated PEG form a covalently
crosslinked copolymer network (PEG:dextran) within seconds to minutes through Schiff
base intermediates (Figure 9).
Figure 8 A dual-chambered syringe equipped with a 12-step mixing tip is used to uniformly mix
PEG amine and dextran aldehyde polymers to yield crosslinked PEG:dextran hydrogels.
Page 33 of 189
.................
Figure 9 Schematic representation of network formation between star PEG amine and dextran
aldehyde. Constituent polymers are crosslinked by imine bonds formed between aldehyde and
amine groups.
The synthesis and preparation of constituent polymers allows for flexibility in a
number of compositional variables in the PEG:dextran system. The following
nomenclature is adopted for the remainder of this work as a means to succinctly
describe a particular material formulation.
Aminated Dolyethylene alycol (P) compositional variables
a. Number of arms per molecule (2 or 8)
b. Molecular weight of PEG molecule (kDa)
c. Solid content (%)
Dextran aldehyde (D) compositional variables
d. Molecular weight (kDa)
e. Oxidative conversion (%)
f. Solid content (%)
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The shorthand notation used to quickly identify the composition of these materials
reads:
P a-b-c D d-e-f
For example, if a 60 kDa, 20% converted, and 50% solid content dextran aldehyde is
polymerized with an 8-arm, 10 kDa, 60% solid content polyethylene glycol, then the
resultant hydrogel is denoted as:
P 8-10-60 D 60-20-50
In addition to the above description, the ratio between aldehyde and amine
concentrations (CHO:NH 2) in a given PEG:dextran formulation is calculated and
provided to reflect the relative reactive group densities of constituent polymers.
Gravimetric analysis of PEG:dextran swell response
The hydration and hydrolytic degradation properties of PEG:dextran hydrogels were
assessed by the swell response of material sample submerged in aqueous media.
Gravimetric data of disk-shaped material samples (Table 1) were collected throughout a
suspension period and used to calculate swelling ratios as follows,
Swelling Ratio (%) W= 100
W,
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where W. is the maximal disk mass measured throughout the suspension period and
WD is the initial disk mass prior to suspension (dry sample). The time point at which the
disk mass peaked and subsequently declined is defined as onset of material
degradation, although it is recognized that this does not strictly reflect degradation
kinetics which proceed at some finite rate immediately upon contact with water. The
present assessment of material swell response is valuable for comparing among
various PEG:dextran formulations but does not provide a rigorous measurement of
network degradation kinetics. Please see appendix for additional detail (Al Swelling and
Degradation).
Table 1 Compositional description of
PEG:dextran variants prepared for
assessment of material swelling and
degradation in an aqueous medium.
P 2-2-50 D 10-50-7 0.96
P 2-2-30 D 60-20-25 2.14
P 2-2-50 D 10-50-20 2.74
P 2-2-50 D 10-50-25 3.42
P 2-2-30 D 10-50-45 10.27
P 8-10-40 D 10-50-5 1.07
P 8-10-38 D 10-50-5 1.13
P 8-10-38 D 60-20-15 1.27
P 8-10-40 D 10-50-14 3.00
P 8-10-20 D 40-25-15 3.04
P 8-10-21 D 60-20-20 3.06
P 8-10-21 D 10-50-14 5.71
P 8-10-10 D 40-25-25 10.15
P 8-10-21 D 10-50-25 10.19
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Uniaxial tensile testinq
*Based on the swelling and degradation data (shown below), present and subsequent
experiments are limited to PEG:dextran formulations featuring constituent star PEG only
(as opposed to linear PEG).
Moderate uniaxial extensions (stretch ratio < 1.15) of dog bone-shaped material
specimens were used to capture the linear elastic deformation regime of PEG:dextran
hydrogels. An ElectroForce® 3450 mechanical tester (22 N load cell, 5 mm
displacement stroke) was used for uniaxial tensile testing. Uniform testing regions (dog
bone shape with rectangular cross section) of cast material samples were extended at
constant displacement rate of 0.05 mm per second with the Electroforce® system (Figure
lo). The force response was recorded by the system load cell and converted to true
stress. The elastic modulus of each PEG:dextran sample is the slope of the generated
true stress versus stretch ratio plot.
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Figure 10 Dog bone-
shaped sample of
PEG:dextran used for
uniaxial tensile testing.
The dog bone-shaped samples of PEG:dextran materials produced for uniaxial
tensile testing do not conform to ASTM standards. The samples used are thicker in the
test region than prescribed by ASTM. Efforts made to cast samples within the
geometrical guidelines were thwarted by an inability to remove polymerized specimens
from the molds without inducing damage. Even when specimens were extracted from
molds in the hydrated state to reduce friability, tears at the material-mold interface
damaged the samples. Nevertheless, the utilized dog bone-shaped geometry was
sufficient to yield repeatable measurements of sample elastic moduli and prevent
material failure at the sample-grip interface.
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The PEG:dextran design space (Table 2) chosen for uniaxial tensile testing facilitates
comparison of material moduli at low and high compositional variable levels in otherwise
identical material pairs (Figure 11). Three such low versus high comparisons were made
for each compositional variable to indicate the relative influence of available constituent
alterations on PEG:dextran modulus. The average change in elastic moduli with each
isolated compositional variation is reported as the main effect. The relative magnitudes
of the variable main effects are used to discern the compositional determinants of
material properties. The benefits and limitations of the utilized main effect analyses
have been previously discussed [50]. Please see appendix for additional detail (A2
Uniaxial Tensile Testing).
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Table 2 Compositional description of
PEG:dextran variants prepared for uniaxial
tensile testing. The materials are selected to
facilitate calculation of compositional variable
main effects on PEG:dextran stiffness.
P 8-2-20 D 10-20-20 0.64
P 8-2-20 D 60-20-20 0.64
P 8-10-60 D 10-20-20 1.07
P 8-10-60 D 60-20-20 1.07
P 8-2-20 D 10-20-40 1.29
P 8-2-20 D 10-50-20 1.71
P 8-10-60 D 10-20-40 2.14
P 8-10-60 D 10-50-20 2.85
P 8-10-20 D 10-20-20 3.21
P 8-10-20 D 60-20-20 3.21
P 8-10-20 D 10-20-40 6.43
P 8-10-20 D 10-50-20 8.56
Dextran Solid Content Main Effect
Dextran Molecular Weight Main Effect
Variable Low VaribeU HIgh
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1=2 P 8-10-60 D 10-20-20 vs P 8-10-60 D60-20-20 Dxt on Mai Effect
P3 
P 8-10-20 D 10-20-20 vs P 8-10-20 D 60-20-20
PEG Molecular Weight Main Effect
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The average change in PEG:dextran modulusfor the three isolated low-
to-h igh variations of constituent d extran molecular weight
Main Effect =
[ (High Varible Modulus) -(Low Variable Modulus) x100(Low Variable Modulus)
PEG Solid Content Main Effect
Figure 11 Schematic of material design space selected to facilitate main effect analyses.
The effect of dextran molecular weight on PEG:dextran modulus is highlighted, although
analogous methodology is applied for all analyzed compositional variables.
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Adhesion strength testing
The adhesive strength of PEG:dextran to the serosal surface of rat small intestine
was measured through application of a tensile force to a tissue-material-tissue interface
(Figure 12). As with uniaxial tensile testing, the material design space for adhesion
strength testing facilitates estimation of compositional variable main effects on the
property of interest (Table 3). Two serosal surfaces are joined with a PEG:dextran
polymer, with subsequent application of a tensile force. The maximal force detected
prior to interface failure reflects the bioadhesive strength of the material formulation.
Please see appendix for additional detail (A3 Adhesion Strength Testing I).
Page 41 of 189
Figure 12 Schematic of adhesion strength testing procedure. Tissue-
material-tissues interfaces are displaced at a constant rate while the force
response is recorded. The maximum force prior to interfacial failure
indicates material adhesion strength.
Table 3 Compositional description of
PEG:dextran variants prepared for adhesion
strength testing. The materials are selected to
facilitate calculation of compositional variable
main effects on PEG:dextran adhesion strength.
P 8-2-20 D 0-20-20 0.64:NH2
P 8-2-20 D 10-20-20 0.64
P 8-2-20 D 60-20-20 0.64
P 8-10-60 D 10-20-20 1.07
P 8-10-60 D 60-20-20 1.07
P 8-2-20 D 10-20-40 1.29
P 8-2-20 D 10-50-20 1.71
P 8-10-60 D 10-20-40 2.14
P 8-10-60 D 10-50-20 2.85
P 8-10-20 D 10-20-20 3.21
P 8-10-20 D 60-20-20 3.21
P 8-10-20 D 10-20-40 6.43
P 8-10-20 D 10-50-20 8.56
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Cytotoxic effect of PEG:dextran degradation products
The response of vascular smooth muscle cells (bovine vSMC) to pooled
PEG:dextran degradation products was quantified with cytotoxicity assays.
Comparisons were made between the degradation products of materials with various
total solid contents and reactive group ratios. The selected materials allow for
comparison of the effects of either material solid content or reactive group ratio at four
levels (Table 4). The first four tabulated samples span a range of wide solid contents
(12.5 %- 42.5 %) with limited variance in reactive group ratio (2.11-2.96), while the
second four samples span a wide range of reactive group ratios (0.42-10.7) with limited
variance in solid content (21.5 %-22.5 %). Please see appendix for additional detail (A4
Cytotoxicity Studies).
Table 4 PEG:dextran variants prepared for assessment of material cytotoxicity. The first
four materials have a range of solid contents and similar reactive group ratios, while the
second four materials have similar solid contents and a range of reactive group ratios.
P 8-10-20 D 10-50-5 12.5 2.14
P 8-10-38 D 60-20-25 31.5 2.11
P 8-10-38 D 60-20-35 36.5 2.96
P 8-10-50 D 60-20-35 42.5 2.25
P 8-10-38 D 60-20-5 21.5 0.42
P 8-10-38 D 10-50-5 21.5 1.13
P 8-10-20 D 60-20-25 22.5 4.02
P 8-10-20 D 10-50-25 22.5 10.7
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Cytotoxicity assay description
A cytotoxicity assay kit (Vybrant) was used to quantify the concentration of the
cytosolic enzyme glucose 6-phosphate dehydrogenase (G6PD) in cell culture
supernatant. The release of this enzyme by cells is indicative of cell damage or death.
The cytotoxic levels (G6PD concentrations) of cell populations subject to various
treatments were converted to a relative cytotoxicity by means of comparison to a lysis
control, which gave the G6PD level for a totally dead cell population of known size. A
Multisizer 3 Coulter Counter (Beckman) was used to count cells populations in 12-well
plates following various culture treatments. The counts provide a basis for adjusting the
relative cytotoxicity measurements to account for well cell density which is subject to a
slight but measurable variance.
The adjusted relative cytotoxicity considers both the size (cell density) and the health
(relative cytotoxicity) of cell cultures after exposure to PEG:dextran degradation
products. The adjusted relative cytotoxicity is a metric for cell culture health, and is
calculated as follows:
Adjusted Relative Cytotoxicity = (Relative Cytotoxicity) / (Cell Density)
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Proliferative effect of polymerized PEG:dextran materials
Fibroblast migration and proliferation are key cellular processes in wound healing
[51-54]. Limitations in the performance of cyanoacrylate polymers have been attributed
to interference with fibroblast activity, resulting in incomplete tissue healing and
increased risk of surgical complications [19, 55]. An ideal tissue sealant would promote
regular fibroblast activity at a wound site, motivating examination of the effect of
PEG:dextran on fibroblast proliferation in vitro. Controlled volumes of PEG:dextran
variants with increasing aldehyde content (Table 5) were applied to sub-confluent 3T3
fibroblasts in culture , which were then allowed to proliferate for an additional 24 hours.
A colorimetric assay was then conducted on the cell cultures to determine the effect of
material exposure on fibroblast proliferation. Please see appendix for additional detail
(A5 Proliferation Studies).
Table 5 PEG:dextran variants prepared for assessment of material effect on fibroblast
proliferation.
P 8-10-50 D1 0-20-20 35 1.29
P 8-10-40 D10-20-20 30 1.61
P 8-10-32 D1 0-20-20 26 2.01
P 8-10-40 D10-50-14 27 3.00
P 8-10-32 D10-50-18 25 4.82
P 8-10-40 D10-50-27 29 5.78
P 8-10-32 D1 0-50-27 29.5 7.22
Proliferation assay description
A MTT colorimetric assay (Chemicon) was used to quantify the proliferation of 3T3
fibroblast cells following various culture treatments. The assay is based on absorbance
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measurements designed to detect the cleavage of 3-(4, 5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrasodium bromide, a process which requires mitochondrial activity. The MTT
assay provides precise measurements of live cell populations, as mitochondrial activity
ceases rapidly following cell death.
Page 46 of 189
-- -- -- Ils I r as-
3.1.4 Results
Swelling ratio and onset of degradation
The swell response of PEG:dextran was gravimetrically monitored over a period of
sustained sample submersion in aqueous medium. The analyses were conducted until
disk fragmentation due to extensive hydrolytic degradation prevented sample handling.
Two descriptors of the swell response were extracted from gravimetric analyses as
described above, specifically the maximal swelling ratio and the onset of material
degradation.
A representative plot of the gravimetric data acquired for PEG:dextran disk
suspensions (P 8-10-40 D 10-50-14, initial mass = 0.34 ± 0.03 g) shows an initial mass
gain due to swell followed by a mass loss due to crosslink degradation and material
erosion (Figure 13). The sample suspension was maintained for 96 hours, with a maximal
mass of 3.26 g measured at the 54 hour time point. The maximal swelling ratio for this
sample is 853.2 % and the onset of degradation occurs after 54 hours of submersion. At
times exceeding 96 hours the sample disk has visibly fragmented and is no longer
appropriate for gravimetric analysis.
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Figure 13 A representative plot of PEG:dextran disk mass as a function of
swell time. Measurements were taken until sample disk fragmentation
prevented handling.
The gravimetric data of PEG:dextran hydrogels portray a wide variance of material
swell response among examined formulations (Table 6). The swelling ratios and
degradation times for the analyzed materials range from -37.3 % to 926.7 % and 0.6
hours to 54 hours, respectively, with a negative swelling ratio indicating a net loss of
mass prior to the first measurement (1 hour). When grouped to reflect the dependence
on the constituent PEG, swelling ratios (Figure 14) and degradation times (Figure 15) are
generally greater with star and opposed to linear polymers, suggesting multiple reactive
arms facilitate polymer network formation and material stability after swell. Furthermore,
the swelling ratio and degradation time across material formulations correlate well with
each other, with a Pearson's correlation coefficient of 0.88 (Figure 16). PEG:dextran
materials featuring star rather than linear PEG constituent are more amenable to clinical
soft tissue sealant applications which generally require material stability for days to
weeks [20].
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Table 6 Summary of the swelling and degradation data
swelling ratio and onset of degradation dramatically
formulations.
for PEG:dextran hydrogels. Both
vary among selected material
Gravimetric anal ses Swellin ratio ) Onset of dogradation (hours
P 2-2-50 D 10-50-7 -37.3 6.0 0.6 0.0
P 2-2-50 D 10-50-20 80.2 9.1 4.7 1.7
P 2-2-30 D 10-50-45 89.0 7.8 6.7 2.3
P 2-2-50 D 10-50-25 95.8 24.1 4.0 0.0
P 2-2-30 D 60-20-25 10.0 2.3 2.0 0.0
P 8-10-10 D 40-25-25 182.1 16.3 8.0 0.0
P 8-10-21 D 10-50-25 621.7 49.8 50.0 3.5
P 8-10-40 D 10-50-5 231.7 76.9 32.3 11.6
P 8-10-38 D 60-20-15 492.6 126.2 46.0 13.9
P 8-10-40 D 10-50-14 926.7 178.1 44.0 10.4
P 8-10-20 D 40-25-15 293.0 44.2 23.8 5.5
P 8-10-21 D 60-20-20 401.0 76.8 44.7 8.0
P 8-10-38 D 10-50-5 217.7 18.0 24.0 0.0
P 8-10-21 D 10-50-14 631.0 83.3 54.0 0.0
M Linear PEG (2-arm)
1500 N Star PEG (8-arm)1500
.2 1100
.E 700
bn 300
-100
PEG:dextran variants
Figure 14 Swelling ratios of PEG:dextran variants, with samples
differentiated only by PEG amine arm number. Formulations with star PEG
exhibited an increased swell response as compared to the linear PEG
alternative.
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Figure 15 Onset of degradation times of PEG:dextran variants, with samples
differentiated only by PEG amine arm number. Formulations with star PEG
exhibited protracted degradation kinetics as compared to the linear PEG
alternative.
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Figure 16 The swelling ratio and onset of degradation of PEG:dextran
variants exhibit a linear correlation, with a Pearson's correlation coefficient
of 0.88 across examined material variants.
Elastic modulus
Uniaxial tensile testing data of PEG:dextran samples were processed to compute
the elastic moduli of selected material formulations. The direct outputs of a uniaxial
tensile test (force versus displacement) were readily transformed into true stress versus
stretch ratio with the appropriate normalizations. A representative plot of PEG:dextran
deformation shows a linear elastic mechanical response (Figure 17). The sample was
elongated to a stretch ratio of 1.12, which corresponds to a 12 % increase in length. The
stress arising in the sample linearly increases in this deformation regime with a slope
indicative of the sample elastic modulus, which was 211 kPa in the representative plot.
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Figure 17 A representative plot of PEG:dextran stress response under
applied unlaxial extension. The slope of stress response Indicates the
material elastic modulus.
The measured elastic moduli of all tested PEG:dextran materials span an order of
magnitude, ranging from approximately 30 - 300 kPa (Table 7). A main effect analysis is
conducted to characterize a PEG:dextran property dependence on available
compositional variation. Main effects provide a rough indication of the influence of each
compositional variable in determining the elastic modulus of PEG:dextran materials. A
positive main effect indicates that increasing the compositional variable value will
increase modulus, while a negative main effect indicates the opposite. Although design
space limitations require careful interpretation of main effect analyses, compositional
determinants of material properties can be confidently inferred in some cases.
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Table 7 Summary of the elastic moduli of PEG:dextran hydrogels as assessed
by uniaxial extension of dog bone-shaped material samples. PEG:dextran
elastic modulus varied by an order-of-magnitude among examined formulations.
Uniaxial tensile testing Elastic modulus (kPa)
P 8-2-20 D 10-20-20 202.4 16.7
P 8-2-20 D 60-20-20 62.9 0.6
P 8-2-20 D 10-20-20 86.2 0.4
P 8-10-20 D 60-20-20 31.9 0.3
P 8-10-20 D 10-20-40 61.5 4.0
P 8-10-20 D 10-50-20 66.0 3.6
P 8-2-20 D 10-20-40 258.1 6.7
P 8-10-20 D 10-50-20 63.9 1.6
P 8-10-60 D 10-20-20 195.3 3.1
P 8-10-60 D 60-20-20 207.9 13.1
P 8-10-60 D 10-20-40 316.4 24.6
P 8-10-60 D 10-50-20 258.2 8.5
The solid content of constituent PEG had an overwhelmingly large positive main
effect (+466.7 %) on PEG:dextran elastic moduli when compared to the other
compositional variables (Table 8). Dextran solid content and oxidation state also have
positive main effects on material modulus, as expected with increased material and
crosslinking density, respectively. The main effects of constituent molecular weights are
relatively slight, but in the case of PEG may reflect a steric inhibition of network
formation for large constituent polymers (a dextran aldehyde polymer may often react
with only a single star PEG amine rather than join two PEG molecules as required in a
network). In any case, molecular weight is a weak determinant of network properties
and offers little control over PEG:dextran modulus.
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Table 8 Main effect analysis reflecting the dependence of PEG:dextran
modulus on compositional variables. PEG solid content exhibited the
strongest influence over material modulus.
Dextran molecular weight 12.8
Dextran oxidation 71.4
Dextran solid content 82.1
PEG molecular weight -55.6
PEG solid content 466.7
Adhesion strenath
Interfaces between excised rat intestinal tissues and PEG:dextran materials were
mechanically tested to rate hydrogel bioadhesive strength. Tissue-material test
elements were subjected to a normal displacement at a constant rate as described
above. The force required to disjoin the interface indicates the adhesive strength of the
material. The force measurements in the developed protocol were invariably small due
to the limited polymer volume applied to the interface (0.25 ml) and to the small
interface contact area (< 1 mm 2). The use of a high fidelity load cell and mechanical
testing system allows for detection of mN forces and facilitates differentiation of
PEG:dextran adhesive strengths with the described testing protocol.
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A representative plot of an interfacial displacement shows an initially increasing
force that peaks around 0.16 N (Figure 18). The maximum force response throughout the
applied interfacial displacement was recorded as the material sample adhesion
strength. After peaking, there is a rapid drop in force which corresponds to interfacial
failure. The adhesion strengths measured for PEG:dextran materials show a large
relative variance, with an absolute span from near 0 to about 0.2 N (Table 9). The
relative adhesion strength of tested compositional variants promotes selection and
design of PEG:dextran for tissue sealant applications.
Figure 18 A representative plot of a tissue-material-tissue interface force
response to uniaxial displacement. The peak force corresponds to
interfacial failure and is indicative of the material adhesion strength.
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Table 9 Summary of the adhesion strength of PEG:dextran hydrogels as assessed
by uniaxial displacement of tissue-material-tissue interfaces.
Adhesion strength testing Adhesion strength (N)
P 8-2-20 D 10-20-20 0.056 0.022
P 8-2-20 D 60-20-20 0.112 0.041
P 8-10-20 D 10-20-20 0.008 0.002
P 8-10-20 D 60-20-20 0.021 0.001
P 8-10-60 D 10-20-20 0.057 0.007
P 8-10-60 D 60-20-20 0.020 0.007
P 8-2-20 D 10-50-20 0.110 0.049
P 8-10-20 D 10-50-20 0.124 0.009
P 8-10-60 D 10-50-20 0.145 0.036
P 8-10-20 D 10-20-40 0.190 0.053
P 8-2-20 D 10-20-40 0.125 0.035
P 8-10-60 D 10-20-40 0.108 0.032
A main effect analysis of the PEG:dextran adhesion strength with compositional
variation is conducted as above (Table o10). The most deterministic variables of adhesion
strength are the constituent dextran oxidation and solid content. The positive main
effects of these compositional variables on adhesion strength are relatively large in
magnitude, and are both related to the number of aldehyde groups in PEG:dextran.
Increasing either the dextran oxidation or solid content in a given material formulation
will result in an increase of free aldehyde content after network formation, provided all
other compositional variables remain unaltered. Based on the main effect analyses,
aldehyde reactivity with tissue is identified as the primary compositional determinant of
PEG:dextran adhesion strength.
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Table 10 Main effect analysis reflecting the dependence of PEG:dextran adhesion
strength on compositional variables. Dextran oxidation state and solid content
exhibited the strongest influence over material adhesion strength, suggesting that
PEG:dextran bioadhesion is achieved via free material aldehyde binding to soft
tissue surfaces.
Dextran molecular weight 26
Dextran oxidation 220
Dextran solid content 170.1
PEG molecular weight 13.9
PEG solid content -4.2
The small negative main effect (-4.2 %) of constituent PEG solid content on
adhesion strength suggests that PEG amine reactivity with tissue is minimal, and is at
most a secondary mechanism for tissue-material interactions. Additionally, studies of
PEG:dextran polymerization rates show that increasing PEG solid content dramatically
reduces the gel time of the tested materials. Accelerated gelling rates will limit the
material spreading (and thus contact area) when polymerized on tissues. The
associated decrease in gelling time and consequentially tissue-material contact area
may explain the negative main effect of PEG solid content observed for PEG:dextran
adhesion strength.
Cytotoxicity of PEG:dextran degradation products
The adjusted relative cytotoxicity following smooth muscle cell exposure to
PEG:dextran degradation products varies with both formulation reactive group ratio and
total solid content (Table 11). In all co-cultures, cellular exposure to pooled PEG:dextran
degradation products results in elevated levels of adjusted relative cytotoxicity. The
general increase in adjusted relative cytotoxicity between early and late degradation
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products of the same material suggests that extensive material degradation is required
to instigate a cellular response.
Table 11 Summary of PEG:dextran degradation product cytotoxicity as indicated by the in vitro
response of bSMC. Degradation products were pooled and applied to cell cultures after one
(early) or three (late) weeks of PEG:dextran suspension in aqueous media.
Early degradation cytotoxicity Late degradation cytotoxicity
Cytotoxicity testing release/cell x 106) (G6PD rlease/cell x 106
DMEM Control 0236 0.113 0.199 0.085
P 8-10-20 D 10-50-5 0.661 0.113 1.233 0.286
P 8-10-38 D 60-20-25 0.444 0.113 0.644 0.051
P 8-10-38 D 60-20-35 0.417 0.103 1.419 0.509
P 8-10-50 D 60-20-35 0.641 0.205 3.355 0.445
P 8-10-38 D 60-20-5 0.734 0.073 3.614 1.294
P 8-10-38 D 10-50-5 0.868 0.122 0.659 0.142
P 8-10-20 D 60-20-25 0265 0.038 0.255 0.106
P 8-10-20 D 10-50-25 0.325 0.096 0.888 0.301
A subset of the adjusted relative cytotoxicity data highlights the effect of total
material solid content variation on the cellular response (Figure 19). A positive correlation
expected between adjusted relative cytotoxicity and material solid content is intuitive
and largely supported by the data, with the exception of the cytotoxic effect of the low
solid content PEG:dextran formulation. The unexpected level of adjusted relative
cytotoxicity with a low solid content PEG:dextran is understood through the degradation
rates operative in these materials. Through visual inspection of material samples, it
appeared that the low solid content formulation had completely dissolved following the
21 day suspension period, while other materials persisted to some extent proportional to
the initial solid content. In other words, the supernatant of 12.5% solid content material
suspension was likely more concentrated with by-product than expected when
considering only initial solid content and ignoring degradation rates. The high level of
cytotoxicity for the low solid content material variant is likely an artifact of increased by-
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product pooling. Positive correlation between solid content and adjusted relative
cytotoxicity is still expected to persist, without exception, once materials have all
undergone complete degradation.
Figure 19 Cytotoxicity of PEG:dextran degradation products
total material solid content.
as a function of
A second subset of the adjusted relative cytotoxicity data shows a more complex
dependence on PEG:dextran reactive group ratio (Figure 20). Material compositions with
exceedingly high or low levels of CHO:NH 2 are relatively cytotoxic upon degradation. An
intermediate reactive group ratio PEG:dextran material (P 8-10-20 D 60-20-25,
CHO:NH 2=4.02) showed no statistically significant difference in cytotoxicity as
compared to DMEM controls. Possible explanations for the exhibited dependence are
discussed below.
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Figure 20 Cytotoxicity of PEG:dextran degradation products
material reactive group ratio.
as a function of
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Proliferative effect of PEG:dextran copolymers
The cellular response to direct applications of PEG:dextran polymers was studied
with a colorimetric proliferation assay. Small volumes of various PEG:dextran materials
were applied to 3T3 fibroblast cultures, which were subsequently incubated for 24 hours
as described above. The cell numbers following incubation with the polymers indicates
the material effects on cell proliferation.
The proliferation data for all tested PEG:dextran materials are represented as a
percent of control samples to which no materials were applied (Table 12). The cellular
response to PEG:dextran polymers ranges from inhibition to stimulation of proliferation.
The significant range in cellular response to PEG:dextran can be expressed as a
function of the material reactive group ratio, and suggests that aldehyde-mediated
reactivity influences proliferation in a dose-dependent manner (Figure 21). As with the
cytotoxicity studies, the in vitro data indicates that PEG:dextran material formulations
with intermediate reactive group ratios (2 - 3) are minimally reactive with cells
Table 12 Summary of the effect of PEG:dextran on fibroblast proliferation in vitro. Data
are presented as a percentage of control wells maintained at standard culture conditions.
Proliferation testin 3T3 proliferation % ositive control
P 8-10-50 D 10-20-20 46.6 16.8
P 8-10-40 D 10-20-20 72.4 12.2
P 8-10-32 D10-20-20 68.6 9.8
P 8-10-40 D10-50-14 116.2 11.3
P 8-10-32 D10-50-18 169.8 28.5
P 8-10-40 D 10-50-27 159.9 14.3
P 8-10-32 D10-50-27 183.8 13.2
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Figure 21 The cellular response to PEG:dextran as a function of material
reactive group ratio. Fibroblast proliferation exhibits a positive dependence
on material aldehyde content.
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3.1.5 Discussion
Soft tissue sealants are a clinically-significant class of biomaterials that provide an
ideal framework for study of tissue-material interactions. Despite extended efforts
toward sealant development, the need for high strength and biocompatible materials
persists within the medical community. We intuit that the challenges in sealant design
fundamentally stem from conflicting dependencies of both tissue response and
bioadhesion on tissue-material interactions. Because these phenomena are readily
quantifiable from an experimental standpoint, tissue sealants facilitate evaluations of
material modifications both in terms of a functional biomaterial gain (i.e. adhesion
strength to soft tissue, leakage prevention at anastomotic junction, adhesive interface
stability) and a prohibitive biological response (i.e. cytotoxicity, tissue inflammation,
immune response).
Through collaboration with industry, we have developed the bioadhesive hydrogel
PEG:dextran which spans a significant property space by virtue of compositional
manipulation. Constituent aminated PEG and dextran aldehyde polymers were
synthesized with a range of molecular weights, solid contents, reactive group densities,
and molecular structures to probe material property response to compositional
variations. Order-of-magnitude differences in multiple material properties were observed
among compositional variants, suggesting that this material system can be optimized
with respect to sealant performance. Here we synthesized a collection of PEG:dextran
materials and compared their swell response, elastic modulus, adhesion strength and
cellular compatibility to determine which compositional variables elicit the greatest
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relative influence over key sealant properties. The results of these initial
characterizations provide guidelines for subsequent use of the PEG:dextran system to
examine tissue-material interactions and further impetus for continued development of
these materials for sealant applications.
When applied to soft tissues in the surgical setting, adhesive materials will be
subjected to biological fluids such as blood, interstitial fluid, and tissue exudates, all of
which have high water content. Accordingly, PEG:dextran hydrogels are expected to
swell in situ, resulting in both a mass gain due to fluid uptake and hydrolytic degradation
of network bonds. Ideal clinical sealants would approximate tissue composition to
promote biocompatibility and would persist as a continuous solid at the application site
for days-to-weeks to provide the desired therapeutic benefit. We found that the eight-
arm star form of constituent PEG amine favors PEG:dextran water uptake and stability
in aqueous suspension, in essence achieving more tissue-like composition for longer
times as compared to the linear alternative. Presumably the multi-functional nature of
star PEG is more conducive to stable network formation due to multiple, near nodes for
aldehyde-amine crosslinking. Future experimentation with PEG:dextran variants will
focus on the star as opposed to linear PEG amine based on the preferred swell
response.
In addition to compositional similitude, mechanical compliance matching between
adhesive materials and soft tissues should be sought to minimize interfacial stress
concentrations. A compliance-matched sealant would likely impart interfacial failure
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resistant under dynamic loading conditions (i.e. a peristaltic wave) and induce less
compression in underlying tissues (as observed with overly stiff cyanoacrylate
materials). In these studies, we found that the stiffness of PEG:dextran is highly
responsive to variations in the solid content of the star PEG amine. Interestingly, the
stiffness dependence on dextran aldehyde solid content is substantially less dramatic,
suggesting that star PEG is the limiting polymer in achieving PEG:dextran network
formation. The observed limitation may stem from a lesser molecular mobility of the
complex macromolecule and a steric hindrance to bond formation introduced by the
presence of multiple arms. Due to the exhibited dependencies, manipulation of PEG
amine solid content will be the employed design strategy for controlling bulk mechanical
properties in the PEG:dextran system.
The primary functional property of soft tissue sealants is clearly bioadhesion. Main
effect analyses of PEG:dextran variants strongly suggest that these materials interact
with soft tissues via aldehyde-mediated bond formation. The total aldehyde density of
PEG:dextran can be readily controlled through the oxidation state and/or solid content
of the dextran aldehyde polymers. Prior to PEG:dextran formation, material aldehyde
groups face four conceivable fates: bonding to amine groups presented by the PEG
constituent (cohesive bond formation), bonding to amine groups on the tissue surface
(adhesive bond formation), chemical conversion (reduction into a primary alcohol or
oxidation into a carboxylic acid), or remaining free. Consequently, aldehyde-mediated
adhesion between PEG:dextran and soft tissue can be directly controlled by the initial
aldehyde density in a particular formulation, but is influenced by the relative amine
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density presented by the PEG component and the target tissue surface. The
identification of the mechanism by which PEG:dextran adheres to tissue enables
rational design for sealant application and facilitates the development of tailored
formulations based on the propensity of target tissue beds for aldehyde-mediated
adhesion.
Excessive bioreactivity can potentially elicit an undesirable biological response and
limit material biocompatibility. In the PEG:dextran system, we demonstrated that
material density (total solid content) and bioreactivity (aldehyde content) interfere with
cellular activities in a complex fashion. Degradation products released from formulations
with extreme levels (low or high) of total solid content or low aldehyde content induced
elevated cytotoxicity in vitro. We attribute these phenomena to the actual amount of
degradation products that accumulate in the culture well plates throughout the duration
of the experiment, which is relatively high in these cases due to either fast degradation
(low solid or low aldehyde content) or more initial material (high solid content). The
highest aldehyde content variant (P 8-10-20 D 10-50-25), although comparatively
stable, also induced increased cytotoxicity upon degradation. In this case, we conclude
that the high concentration of bioreactive aldehyde groups is the cause of by-product
cytotoxicity. This, along with the observed monotonic increase in cellular proliferation
with CHO:NH 2, suggest that arbitrarily increasing the aldehyde content in PEG:dextran
will reduce material biocompatibility throughout the implantation period.
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Preliminary characterizations of PEG:dextran demonstrate the property span
possible with this material system. Key properties, including material swell response,
stiffness, bioadhesion strength, and cellular compatibility, all vary among material
formulations in a predicable manner. Future studies will exploit the identified material-
property relationships in order to better understand tissue-material interactions and
appropriate PEG:dextran for clinical sealant applications.
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3.1.6 Conclusion
PEG:dextran hydrogels constitute a family of bioadhesive materials with potential for
medical use as soft tissue sealants. In this preliminary work we identified compositional
variables which have the strongest relative influence on central material properties, thus
providing a basis for future rational design of PEG:dextran sealants. The following
property determinants have been identified for the PEG:dextran material system.
1. Network complexity (constituent PEG arm number) determines material hydration
and stability in an aqueous environment
2. Constituent PEG solid content determines elastic modulus
3. Aldehyde reactivity determines adhesion strength to tissue
4. Reactive group ratio determines material biocompatibility
Identification of these compositional determinants not only guides PEG:dextran
development for bioadhesive applications but additionally suggests underlying
mechanisms of tissue-material interaction between these complex polymers and soft
tissue. Future work will focus on additional characterization of PEG:dextran property
response to compositional variation, constitutive modeling of adhesive mechanics,
analyses of in vivo tissue response to PEG:dextran, in vitro-in vivo data correlation, and
ultimately the integration of experimental data to gain mechanistic understanding of
adhesive tissue-material interactions and overall sealant performance.
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3.1.7 Study Transition
The characterizations of PEG:dextran presented in Study 1 demonstrate that
hydrogel cohesion and adhesion are highly responsive to compositional variations.
More importantly, the identified property determinants provide rationale for designing
families of PEG:dextran most appropriate for probing particular tissue-material
interactions and advancing the potential of these materials as clinical sealants. The
primary functional property of sealants is tissue-material adhesion, which we are now
poised to strategically analyze with the PEG:dextran system. We anticipate that
alteration in PEG:dextran aldehyde content will elicit control of adhesion to duodenal
tissue, and that a series of materials with increasing aldehyde content can be used to
correlate between adhesive properties and tissue response. To this end, we next
synthesize the proposed material series, construct a constitutive model of adhesion,
and apply model predictions to understand better the relationships between adhesion
and tissue response which govern overall sealant performance.
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3.2.1 Abstract
Soft tissue sealants generally sacrifice adhesive strength for biocompatibility,
motivating the development of materials which interact with tissue to a predictable and
controllable extent. Crosslinked hydrogels comprising aminated star polyethylene glycol
and high molecular weight dextran aldehyde polymers (PEG:dextran) display aldehyde-
mediated adhesion and readily tunable reactivity with soft tissue ex vivo. Evaluation of
PEG:dextran compositional variants revealed that the burst pressure of repaired
intestinal wounds and the extent of material-induced tissue deformation both increase
nonlinearly with formulation aldehyde content and are consistently within the desired
range established by traditional sealants. Adhesive test elements featuring PEG:dextran
and intestinal tissue exhibited considerable viscoelasticity, prompting use of a standard
linear solid (SLS) model to describe adhesive mechanics. Model elements were
accurately represented as continuous functions of PEG:dextran chemistry, facilitating
prediction of adhesive mechanics across the examined range of compositional
formulations. SLS models of traditional sealants were also constructed to allow general
correlative analyses between viscoelastic adhesive mechanics and metrics of sealant
performance. Linear correlation of equilibrium SLS stiffness to sealant-induced tissue
deformation indicates dense adhesive crosslinking restricts tissue expansion, while
correlation of instantaneous SLS stiffness to burst pressure suggests the adhesive
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VISCOELASTIC MODEL OF ADHESIVE MECHANICS3.2 STUDY 2
stress relaxation capacity of PEG:dextran enhances their overall performance relative to
traditional sealants.
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3.2.2 Introduction
Adhesive sealants assist tissue repair and reduce operative risk through
anastomotic stabilization, promotion of wound healing between disjoined tissues, and
induction of rapid hemostasis [6-8]. Bioadhesive properties are largely a consequence
of material reactivity with tissue, and as a result controlling unintended and deleterious
reactivity is a major challenge of sealant design [56]. Tradeoffs between various
adhesive properties dependent on bioreactivity are exemplified by common
cyanoacrylate- and fibrin-based sealants [13-15]. Cyanoacrylate derivatives are highly
bioreactive and adhere strongly to tissue, but are clinically limited due to excessive
inflammation upon application and the release of cytotoxic by-products [18, 19]. Fibrin
sealants are generally more biocompatible, but weakly adhere to tissue and introduce a
risk of infectious transmission given their biological origin [7, 16, 17, 57]. A clear need
persists for a soft tissue sealant capable of high strength and prolonged adhesion with
minimal immune or inflammatory response.
Limitations of existing sealants could in part reflect a disturbance in underlying tissue
mechanics following adhesive bond formation. Many soft tissues are viscoelastic and
entropically dissipate significant amounts of mechanical stress under physiologic
loading [58-61]. Highly reactive cyanoacrylate derivatives achieve high strength
bioadhesion but in doing so may reduce native viscoelasticity as a consequence of low
molecular weight tissue crosslinking. Conversely, less adherent fibrin sealants will likely
maintain tissue viscoelasticity but cannot provide the mechanical strength necessary for
wound stabilization and other clinical applications [62]. A viscoelastic model of adhesive
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mechanics could meaningfully describe tissue-material interactions and facilitate
correlation of mechanical properties with ultimate function.
Biomaterial applications of both star polyethylene glycol (PEG) and various
polysaccharides have been extensively studied [49, 63-67]. Clinical interest in these
materials has emerged because of their excellent biocompatibility, readily modifiable
chemistries, and capability to form tissue-like hydrogel matrices. Here, crosslinked
hydrogels composed of various ratios of aminated star PEG and dextran aldehyde
polymers (PEG:dextran) were evaluated as potential soft tissue sealants with tunable
adhesive properties [45, 46]. We hypothesized that the aldehyde content of
PEG:dextran hydrogels will heavily influence their adhesion, and that the large reactive
polymer constituent (10 kDa dextran aldehyde) will allow viscoelastic adhesive
crosslinking. Adhesion of PEG:dextran to soft tissue should contrast the effect of small
aldehyde-based fixatives, such as formaldehyde and glutaraldehyde, which tightly
crosslink tissues and radically alter their physical and mechanical properties [68].
A series of PEG:dextran formulations with increasing aldehyde content were
synthesized to examine the impact of aldehyde-mediated interactions on functional
adhesive properties. Burst pressure of repaired intestinal wounds and the extent of
material-induced tissue deformation served as ex vivo metrics of sealant performance.
Tensile testing of adhesive constructs was used to probe the viscoelastic properties of
PEG:dextran-tissue interactions and allow development of a standard linear solid (SLS)
model relating adhesive mechanics to material chemistry. Additional mechanical testing
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and SLS modeling of traditional fibrin and octyl-cyanoacrylate sealants promoted
general relation of viscoelastic adhesive mechanics to ex vivo performance metrics.
Correlative analyses revealed that adhesive bond density is a primary determinant of
sealant functionality, and further suggested that overall performance is enhanced
through operational stress relaxation mechanisms following PEG:dextran adhesion to
soft tissue.
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3.2.3 Materials and Methods
Synthesis and network formation of PEG:dextran
The synthesis of star PEG amine and dextran aldehyde as well as the network
formation of PEG:dextran have been previously described [45, 46]. Briefly, eight-arm,
10 kDa star PEG polymer with amine end groups was dissolved in water to form a 25 wt
% aqueous solution. Linear dextran (10 kDa) was oxidized with sodium periodate to
yield dextran aldehyde polymer (50 % oxidation of glucose rings, 2 aldehyde groups per
oxidized glucose ring), which was also prepared as an aqueous solution (2.95 - 20.65
wt %). The two homogeneous polymer solutions were loaded into a dual-chamber
syringe equipped with a 12-step mixing tip. PEG:dextran network formation occurs
within seconds to minutes following the injection and controlled mixing of PEG amine
and dextran aldehyde via a Schiff's base reaction between the constituent reactive
groups (aldehydes and amines).
Selection and designation of PEG:dextran variants
Compositional variables of both star PEG amine and dextran aldehyde are easily
manipulated in the synthesis of PEG:dextran. The solid contents, molecular weights,
and reactive group content of polymer constituents are readily altered to achieve
crosslinked networks with distinct material properties [45, 46]. The present study
focused on examining the effects of relative aldehyde concentration on adhesive
mechanics, motivating the synthesis of a series of material formulations with isolated
variation in dextran aldehyde solid content. As star PEG amine compositional variables
(and consequently amine group concentrations) are held constant, the formulations
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under study are meaningfully differentiated by the ratio of aldehyde to amine reactive
group concentrations, designated as CHO:NH 2 (Table 13).
Table 13 Compositional description of the examined five-material series of PEG:dextran
PEG amine Dextran aldehyde PEG:dextran
Arm Molecular Solid Amine Molecular Percent Solid Aldehyde Reactive
Number Weight Content Content Weight Oxidation Content Content Group Ratio
# (kDa) ( (# per ml) (kDa) (%) (%) (# oper ml) (CHO:NH,)
8 10 25 1.2 x1020 10 50 2.95 1.2 x,102 1
8 10 25 1.2 x10 20  10 50 5.90 2.4 x10 2 0  2
8 10 25 1.2 x10 20  10 50 8.85 3.6 x10 20  3
8 10 25 1.2 x10 20  10 50 14.75 6.0 x10 20  5
8 10 25 1.2 x10 20 10 50 20.65 8.4 x 21 7
Wounding, repair, and dynamic loading of intestinal tissue
Adult Sprague-Dawley rats (250 - 300 g, Charles River Laboratories, MA) were
sacrificed via carbon dioxide asphyxiation under university IACUC protocol and federal
guidelines for animal care. Following sacrifice, the duodenum was immediately excised
and immersed in 10 ml Krebs-Henseleit buffer at room temperature. Longitudinal
duodenal segments were cut and inserted into a mechanical testing apparatus
configured for luminal perfusion (Bose@ Biodynamic Test Instrument, Minnetonka, MN).
A wound was introduced by full-thickness puncturing of the intestinal wall with an 18
gauge needle. Wounds were then repaired with a 200 pl application of PEG:dextran,
octyl-cyanoacrylate (Dermabond, Ethicon Inc.), or fibrin sealant (Calbiochem) to the
outer intestinal surface. A five minute sealant curing time was allowed, after which
pulsatile loads were applied through controlled perfusion of the intestine lumen with
phosphate buffered saline (PBS). All repair sites featuring PEG:dextran variants
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remained intact throughout loading, substantiating clinical potential of these materials as
a soft tissue sealing agent (Figure 22).
Figure 22 The tissue-material interface formed between the serosal surface of excised rat
duodenum and PEG:dextran appeared continuous after histological processing (cryo-
sectioning, hematoxylin and eosin stain) and microscopic analysis (left). Following
sinusoidal loading (frequency =1 Hz, amplitude = 25 mmHg, cycle number = 1000) the
interface remained well intact with no indication of material detachment (right). Scale bars
are 1 mm and arrows indicate the location of tissue-material interface.
Measurement of burst pressure and tissue deformation
The burst pressure of repaired intestinal wounds (prepared and treated as above)
was measured through gradual increase of lumen pressure. A slow development of
pressure was achieved through restriction of flow distal to the sample lumen and
monitored at the inlet of the intestine. The burst pressure was easily detected in this
manner, as failure of the repair site resulted in an immediate loss of developed inlet
pressure and visible PBS leakage. The maximum luminal pressure prior to interface
failure was recorded as the wound burst pressure. Please see appendix for additional
detail (A6 Burst Pressure Testing).
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The tissue response to wound repair and loading was assessed through histological
processing (hematoxylin and eosin stain) and numerical image analyses (Matlab,
Mathworks Inc.) of intestinal samples. The reduction of lumen area directly adjacent to
the material application site was chosen as a performance metric to indicate the extent
to which wound repair and loading altered local tissue architecture. Please see
appendix for additional detail (A7 Lumen Area Determination).
Stress relaxation of intestinal tissue and bulk PEG:dextran
Intestinal ring samples were prepared by transversely sectioning rat duodenum
immediately after sacrifice and tissue excision. Ring samples of approximately 3 mm
width were inserted into a mechanical testing apparatus configured for tensile testing
(Bose@ Biodynamic Test Instrument, Minnetonka, MN). Tissue samples were fixed in
the mechanical tester such that the displacement axis was coincident with the ring radial
direction. A programmed step displacement was used to impart a 0.2 tensile strain for
six minutes, with continuous acquisition (scan rate of 50/sec) of the resultant force via
the system load cell and software package (WinTest@ Software, Minnetonka, MN).
Mechanical data were processed to yield a tissue stress relaxation curve.
The viscoelastic response of a representative PEG:dextran material was also
analyzed under constant applied displacement. Test samples were prepared by
polymerization of PEG:dextran in Lexan strip molds with oversized ends, allowing
secure attachment to soft-sample clamps of the mechanical testing apparatus.
Following a cure time of five minutes, strip samples were moderately hydrated with a 10
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ml PBS rinse over surfaces within the test region. As before, a tensile strain of 0.2 was
applied for six minutes through a programmed step displacement. The resultant load
data were acquired and processed to yield a bulk PEG:dextran stress relaxation curve.
Bulk PEG:dextran stiffness
Ramped uniaxial displacements (displacement rate of .05 mm/sec) were applied to
bulk strip samples of PEG:dextran materials (prepared and treated as above) with a
mechanical testing apparatus configured for tensile testing (Bose@ Biodynamic Test
Instrument, Minnetonka, MN). Resultant force and displacement data were continuously
recorded (scan rate 200/sec) throughout mechanical testing by the system load cell and
software package (WinTest@ Software, Minnetonka, MN). Force versus displacement
data were transformed into true stress versus strain for each test sample, facilitating
calculation of bulk elastic moduli.
PEG:dextran gelation time
The gelation times of PEG:dextran formulations were determined through constant
agitation and visual monitoring of material components undergoing network formation.
Material samples were injected into glass plates through dual-chamber syringes
equipped with mixing tips. A magnetic stir rod was used to agitate samples immediately
following the mixed injection. The gelation time of each material sample was designated
as the elapsed time after injection at which the stir rod rotation was hindered due to the
progression of PEG:dextran network formation.
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Stress relaxation of adhesive test elements
The small intestines of adult Sprague-Dawley rats were excised and immersed in
buffer as above. Approximately two cm-long segments were cut from the duodenum
and bisected along the mesenteric line, creating intestinal sheets. Surface samples
were constructed by securing an intestinal sheet over a tubular fitting, consistently
providing a flat and stable presentation of the outer serosal surface. Samples were
inserted into the upper and lower arms of a mechanical testing apparatus configured for
tensile testing (Bose@ Biodynamic Test Instrument, Minnetonka, MN). A 50 pl volume of
test sealant was then applied directly to the lower intestinal surface. The upper and
lower intestinal surfaces were immediately brought into contact, and the adhesive
material allowed to cure between the tissues for five minutes under a 0.3 N setting
force. The tissues and adhesive were subsequently rinsed with two ml PBS, with
particular focus on the interfacial region. The described tissue-material configuration
provided convenient adhesive test elements for analysis under constant tensile
displacement. Please see appendix for additional detail (A8 Adhesion Strength Testing II)
Stress relaxation of adhesive test elements featuring PEG:dextran, octyl-
cyanoacrylate, or fibrin sealant was measured following application of a 0.2 mm step
displacement for a five minute period. Load data were converted to engineering stress
and plotted as a function of time, providing a measure of the test element viscoelasticity
following tissue-material interaction.
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3.2.4 Results
Burst pressure and tissue response following dynamic loading
Excised intestinal tissues were puncture wounded and repaired with PEG:dextran,
octyl-cyanoacrylate (CA), or fibrin sealant (FG). Following repair, pulsatile loads were
applied to tissue samples through programmed luminal perfusion with PBS. No
leakages were detected and all tissue-material interfaces consistently appeared intact
and continuous throughout loading. Adhesive failure resistance was quantified through
gradual pressurization of sample lumens and reported as the burst pressure of the
tissue-material interface. PEG:dextran application burst pressure ranged from 62.2 +
4.8 to 112.0 ± 9.5 mmHg and rose nonlinearly with CHO:NH 2 (Figure 23). The CA-tissue
interface had a comparatively higher burst pressure of 132.5 ± 5.8 mmHg, while the FG-
tissue interface burst at a lower pressure of 52.0 + 6.1 mmHg.
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Figure 23 Burst pressure of wounded intestinal tissue (length = 4 cm)
repaired with PEG:dextran nonlinearly rose with CHO:NH 2 across the
examined range. Data points represent averages ± SEM (n = 4 - 5).
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Wound repair and cyclical loading consistently induced compressive tissue
deformation local to sealant applications. Specifically, the retained intestinal lumen area
after PEG:dextran treatment ranged from 57.5 ± 5.74 to 74.2 ± 9.4 % of native
dimensions, with increased CHO:NH 2 initially causing more compression but reaching a
threshold value (Figure 24). CA and FG elicited comparatively more or less deformation,
with retained lumen area of 24.2 + 0.9 % and 84.8 ± 8.7 %, respectively.
100
C 75
c 50
E
=J
25
0 2 4 6 8
CHO:NH 2
Figure 24 The percent retention of native lumen area following PEG:dextran
wound repair and cyclical loading initially decreased with CHO:NH2 but
approached a threshold value. Data points represent averages ± SEM (n = 4
- 5)
Properties of interfacial components in isolation
PEG:dextran materials were studied in isolation to elucidate the dependence of
network formation on constituent reactive chemistry. CHO:NH 2 variation imparted order
of magnitude ranges of bulk elastic moduli (16.1 ± 0.8 to 161.0 ± 10.8 kPa) and gelation
times (6.7 ± 2.5 to 69.2 ± 7.5 sec), demonstrating a significant network response to
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aldehyde density (Figure 25 and Figure 26). Trends in elastic moduli and gelation time
illustrate that CHO:NH 2 increase yields stiffer networks which form in less time.
However, both bulk properties have a reduced sensitivity to CHO:NH 2 at higher
aldehyde content (CHO:NH 2 > 3), suggesting that the extent and kinetics of network
formation approach saturation at critical concentrations of constituent dextran aldehyde.
Figure 25 The elastic moduli (uniaxial tensile test parameters of strain rate =
0.005/sec, final strain = 0.1) of PEG:dextran are highly responsive to
CHO:NH2, with order of magnitude variances across material formulations.
Data points represent averages ± SEM (n = 4 - 5)
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Figure 26 The gelation times (1 ml total material volume) of PEG:dextran are
highly responsive to CHO:NH2, with order of magnitude variances across
material formulations. Material properties have reduced sensitivity to
aldehyde content when CHO:NH2 > 3, Indicating approach to a threshold
value. Data points represent averages t SEM (n = 4 - 5)
An intermediate PEG:dextran formulation (CHO:NH 2 of 3) and excised intestinal
tissue were individually examined under constant strain (Figure 27). PEG:dextran
exhibited notable viscoelasticity, as the instantaneous stress of 28.0 ± 4.3 kPa relaxed
to 19.6 ± 2.9 kPa throughout the observation time, while intestinal tissue relaxed more
extensively from an instantaneous stress of 20.1 ± 1.3 kPa to 4.9 ± 0.3 kPa.
Viscoelastic relaxation mechanisms have presumably evolved in many soft tissues to
passively dissipate wall stress under low frequency loading, as particularly characteristic
of the digestive process. Both bulk PEG:dextran and tissue relax stress, suggesting that
tissue-material adhesive constructs composed of the two may also behave as
viscoelastic solids.
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Figure 27 Bulk PEG:dextran (CHO:NH2 = 3, sample dimensions of length =
10 mm, width = 8 mm, thickness = 4 mm, n = 3) and rat intestine ring
samples (ring width = 3 mm, n = 3) exhibited stress relaxation in response to
a maintained 0.2 strain. The instantaneous tissue stress was approximately
20 kPa, and relaxed to an equilibrium value of 5 kPa over the 400 sec
observation time. The bulk PEG:dextran was notably stiffer, with an
instantaneous stress of approximately 33 kPa partially relaxing to 22 kPa
over the same time period.
Stress relaxation of adhesive test elements
The viscoelastic behavior of soft tissue adhesion was assessed through the stress
relaxation exhibited by tissue-material constructs. Adhesive test elements comprising
sealants and intestinal tissue were held at a 0.2 strain, with constant monitoring of
resultant loads. All PEG:dextran test elements instantaneously experience a maximal
adhesive stress followed by relaxation to an equilibrium value within 300 seconds (Figure
28). PEG:dextran adhesive mechanics were responsive to CHO:NH 2 variation, with
instantaneous and equilibrium stress ranges of 2.0 ± 0.2 to 7.1 ± 0.5 kPa and 1.4 ± 0.1
to 3.2 ± 0.5 kPa, respectively. The vertical shift of relaxation curves with increasing
CHO:NH 2 parenthetically supports the notion of aldehyde-mediated reactivity with soft
tissue. The viscoelastic adhesive mechanics of tissue-material test elements comprising
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CA and FG bracketed those of PEG:dextran variants, as the former displayed elevated
and the latter reduced stresses.
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Figure 28 Adhesive test element composed of traditional (CA=cyanoacrylate, FG=Fibrin glue) and
PEG:dextran (number denotes formulation CHO:NH 2) exhibited substantial stress relaxation over
five minutes of maintained displacement. PEG:dextran stress relaxation closely follows curves(colored lines) generated with mechanical modeling.
Stress relaxation is derived from the capacity of materials or composite structures to
reduce conformational entropy through stress-oriented molecular extensions [69].
Comparison of the instantaneous, equilibrium, and relaxed stress demonstrated that
PEG:dextran adhesive constructs relaxed significant fractions of instantaneous stress,
with the total amount of relaxed stress generally rising with CHO:NH 2. CA-tissue
adhesion achieved high instantaneous stress but underwent minor relative relaxation to
reach the equilibrium state, while FG-tissue constructs underwent a substantial relative
relaxation but dissipated little overall stress due to a diminished instantaneous response
(Table 14).
Page 86 of 189
~ -1 I~----~
Table 14 Comparison between the instantaneous, equilibrium, and relaxed stress exhibit by
adhesive test elements featuring PEG:dextran, octyl-cyanoacrylate (CA), and fibrin (FG) sealants.
Table entries represents average ± SEM (n =3-5).
PEG:dextran Variants (CHO:NH 2) Traditional Sealants
1 2 3 5 7 FG OC
InstantaneousStress 2.0 +0.2 2.9 ± 0.1 4.7±0.3 5.1±0.4 7.1 ± 0.5 2.2 ± 0.2 11.4 ± 0.6(kPa)
Equilibrium Stress 1.4 0.1 2.0 0.1 2.7 0.3 3.2 +0.2 3.2 +0.5 1.4 0.3 10.3 +0.2
(kPa)
Relaxed Stress 0.6 ± 0.2 0.9 ± 0.1 2.0 ± 0.4 1.9 ± 0.4 3.9 ± 0.7 0.8 ± 0.3 1.1 ± 0.5(kPa)
RelativeRelaxation 30 ± 10 31 + 3.6 43 + 8.9 37 + 8.4 55 ± 10 36 ± 14 10 ± 4.3
(%)
The stress relaxations of adhesive test elements mimic the response of viscoelastic
solids, motivating the use of a standard linear solid (SLS) model to describe adhesive
mechanics (Figure 29). Model elements consist of a spring (equilibrium arm) arranged in
parallel with a series spring and dashpot (Maxwell arm). Although this SLS modeling
approach does not inform on the mechanics of individual interfacial components (two
tissue layers, two tissue-material interfaces, and the material layer), it instead lumps
together elemental contributions and represents the cumulative mechanical
environment following tissue-material interaction. In the following section, stress
relaxation data are used to develop, functionalize, and verify a SLS model of
PEG:dextran adhesive mechanics.
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Figure 29 The viscoelasticity of adhesive test elements (left) was modeled with a standard
linear solid (right). The equilibrium arm features a single spring of stiffness Ke and models
time-invariant adhesive mechanics. The Maxwell arm is composed of a spring of stiffness K1
in series with a dashpot of viscosity r and models dynamic adhesive mechanics.
Application of the standard linear solid model to adhesive mechanics
SLS model development
The governing SLS differential equation is displayed in Eq. 1, where a is the
adhesive stress and E is the tensile strain. The model elements and descriptors of SLS
mechanics are the equilibrium spring with stiffness Ke [kPa], Maxwell spring with
stiffness K1 [kPa], and Maxwell dashpot with viscosity r [kPa-sec]. The relaxation time
constant T [sec] characterizes the kinetics of viscoelastic adhesive mechanics and is
calculated from Maxwell arm components as T = r/ K. In the following treatment, SLS
element descriptors are represented as functions of CHO:NH 2, providing a means of
incorporating PEG:dextran compositional information into an adhesive mechanical
model.
The constitutive equation is readily solved for the case of a constant strain Eo,
yielding a mathematical description of adhesive stress relaxation (Eq. 2). Model
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descriptors are adjusted to fit the experimental data and complete generation of the
viscoelastic constitutive equations. The modeled response for each PEG:dextran
formulation is plotted along with experimental data as a solid colored line (Figure 28). High
Pearson's correlation (R > 0.98 in all cases) between the modeled responses and
experimental data support the choice of viscoelastic theory and particularly the SLS to
describe adhesive mechanics.
da 1 dE K
-+-a = [Ke + K,]-+ K E (1)
dt r dt r
o(t) -t
= Ke + K,eT  (2)
Equilibrium and Maxwell arm descriptors are plotted are analyzed functions of
CHO:NH 2 to delineate the dependencies of steady state and dynamic adhesive
mechanics on PEG:dextran composition. The SLS equilibrium stiffness is interpreted as
an indicator of tissue-material reactivity and resultant adhesive bond density, while
Maxwell variables reflect the available molecular mobility and stress relaxation following
adhesive interaction. The rise of Ke with CHO:NH 2 implies aldehyde-mediated reactivity
with tissue, although the nearly identical values of the 5 and 7 formulations (15.8 and
15.9 kPa, respectively) suggest a threshold to the adhesive bond density achievable
through isolated variations of dextran aldehyde solid content (Figure 30).
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Figure 30 SLS equilibrium arm stiffness Ke quadratically varied with
CHO:NH 2 across PEG:dextran variants (R = 0.99), indicating an initial
increase and eventual saturation of aldehyde-mediated adhesive bond
formation.
Because aldehyde variation was achieved through increase in material solid content,
the rise of K1 with CHO:NH 2 is attributed to the increased number of dextran chains
undergoing relaxation both within the PEG:dextran bulk and at the tissue-material
interface (Figure 31). The inflection of the quadratic r curve within the examined CHO:NH2
range demonstrates that adhesive relaxation mechanisms have maximally protracted
kinetics at intermediate aldehyde content (Figure 32). AS T depends on r and Ki, reduced
value at low CHO:NH 2 likely reflects high interfacial and network flow (low 17) due to
relatively sparse aldehyde bonding with tissue and within the bulk, while low r at high
CHO:NH 2 likely stems from a high aldehyde bond density and extensive molecular
relaxation (elevated K). Theoretical reasons for these relationships are extended
below, along with associated implications for and correlations to sealant efficacy.
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Figure 31 Maxwell arm stiffness K1 linearly varied with CHO:NH 2 (R = 0.94),
suggesting increased aldehyde content enhances the stress relaxation
capacity of PEG:dextran adhesive constructs throughout the examined
compositional range.
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Figure 32 Maxwell arm time constant T quadratically varied with CHO:NH 2, (R
= 0.94), with a clear inflection representing at kinetic maximum within the
material design space
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SLS model validation
The functional SLS model is validated through correlation analyses of predicted and
measured adhesive mechanics featuring PEG:dextran formulations within the examined
compositional range (CHO:NH 2 of 1.5, 2.5, and 6). These materials are synthesized with
the same polymer constituents described in Table 1, again varying only in solid content
of the dextran aldehyde component. PEG:dextran formulations with CHO:NH 2 of 1.5,
2.5, and 6 are synthesized with 4.4, 7.4, and 17.7 percent solid content of dextran
aldehyde, respectively.
Predicted adhesive stress relaxation curves for PEG:dextran variants were
generated with Eq. 2 and interpolation of model element values. Modeled stress
relaxations generated with these methods correlate well to experimental data (Figure 33),
with a high Pearson's coefficients in all cases (R1 .5 = 0.98, R2.5 = 0.96, R6 = 0.98).
Successful prediction of adhesive mechanics demonstrates SLS parameter continuity
within the design space and the potential for strategic adjustment of PEG:dextran
composition to meet various application requirements.
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Figure 33 The viscoelastic responses of PEG:dextran adhesive test
elements formed with in-range formulations (CHO:NH 2 = 1.5 , 2.5, and 6)
were predicted based on above regressions and governing constitutive
equations. The modeled responses (lines) correlated well with experimental
stress relaxation data (data points) for both PEG:dextran formulations (R 1.s5
= 0.98, R 2.5 = 0.96, R 6 = 0.98). Data points represent averages + SEM (n = 4 -
5)
Correlation analyses
Correlations between PEG:dextran material properties and sealant performance
metrics suggest a proportional positive influence of increased aldehyde content on both
network formation and tissue-material interaction. Specifically, PEG:dextran elastic
modulus and gelation time strongly correlated to both wound burst pressure and
retained lumen area across the examined range of CHO:NH 2 (IRI > 0.98 in all Pearson's
correlation two-way analyses). It is important to note that linear correlations generally do
not persist if PEG:dextran composition is systematically altered in a fashion other than
via aldehyde content. For example, increasing the solid content of constituent PEG
amine will dramatically increase the elastic modulus of PEG:dextran without any
significant change to adhesive performance (data not shown).
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SLS variable descriptor Ke inversely correlated (R = -0.95) to the percent retention of
lumen area over all PEG:dextran, FG, and CA sealants (Figure 34). Ke reflects the
equilibrium mechanical state exhibited by a fully relaxed interface and is presumed
proportional to the tissue-material adhesive bond density. Inverse correlation to Ke
indicates that disturbance of tissue structure is more severe with increased adhesive
bonding. Wound burst pressure strongly correlated to Ke with the exception of the CA
samples, both reinforcing the import of adhesive bond density and suggesting a role for
auxiliary factors (Figure 35). SLS modeling facilitated examination of potential secondary
mechanical factors, particularly the extent (via K) and kinetics (via T) of available stress
relaxation. Linear correlation of burst pressure across all materials is moderately
attained (R = 0.94) when analyzed against the instantaneous SLS stiffness (Ke + K)
(Figure 36). Burst pressure correlation to instantaneous stiffness implicates available
adhesive relaxation as an influential factor determining performance, with the capability
to entropically dissipate stress improving sealant function. Performance metric
correlations to SLS variables suggest that both adhesive bond density and available
stress relaxation will together determine overall sealant efficacy.
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Figure 34 Performance metric correlations to SLS model descriptors
revealed the influence of separable aspects of viscoelastic adhesive
mechanics on burst pressure and local tissue response. Equilibrium
stiffness Ke inversely correlated (R = -0.95) to retained lumen area across
PEG:dextran (e), fibrin (FG, A), and octyl-cyanoacrylate (OC, m) samples,
indicating higher adhesive bond density compromised local tissue structure
Figure 35 The burst pressure of PEG:dextran and FG
strong linear correlation to Ke, while the CA samples
from this trend.
repaired wounds had
dramatically diverged
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Figure 36 Burst pressure across all sealant types showed significant linear
correlation (R = 0.94) to the instantaneous interfacial stiffness (Ks + K1),
implicating the ability to relax stress as an additional factor governing
failure resistance following material application and cyclical loading.
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3.2.5 Discussion
Ex vivo metrics of PEG:dextran sealant performance varied with the constituent
aldehyde content and were within the range of clinically available fibrin (FG) and octyl-
cyanoacrylate (CA) sealants. Solid modeling of tissue-material test element mechanics
effectively described adhesive stress relaxation and distinguished viscous and elastic
characteristics governing sealant performance. Correlation analyses of model variable
descriptors to performance metrics of PEG:dextran, CA, and FG supported the
expected influence of tissue-material reactivity on sealant functionality and tissue
response, and also brought forth the benefit of maintaining a stress relaxation capacity
after adhesion. PEG:dextran sealants clearly demonstrated aldehyde-mediated
adhesion and a substantial capacity to relax adhesive stress in a test element
configuration.
Viscoelastic adhesive mechanics imply macromolecular mobility within the tissue,
material, and/or interface, and provide a mechanism for entropic dissipation of
mechanical work imparted to the application site. If macromolecular mobility is limited by
tissue-material crosslinking, adhesive stress will result in an increase of internal bond
energies in lieu of an entropic mechanical response. The microscopic breaking of
adhesive bonds will occur at a critical bond energy and macroscopically manifest as
adhesive failure. Thus, given two equally crosslinked tissue-material interfaces under
identical loading conditions, the more viscoelastic interface should have a greater failure
resistance by virtue of bond energy minimization. The developed SLS modeling scheme
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of PEG:dextran adhesion provides a computational tool for predicting viscoelastic
mechanics and can facilitate the design of failure-resistant material formulations.
Saturation and eventual loss of all solid-like properties with increasing aldehyde
content is expected in the PEG:dextran system. In the limit where CHO:NH 2 approaches
infinity, the dextran aldehyde component will remain soluble and formation of a
crosslinked gel is lost. Prior to the anticipated compositional threshold, aldehyde-
mediated chemistry should play a key role in both PEG:dextran network formation and
reaction with tissue and insomuch provide an efficient vehicle for control of bulk and
adhesive properties. Strong dependencies of pertinent PEG:dextran properties on
aldehyde content clearly emerged throughout this study. Furthermore, property trends
indicate that the influences of aldehyde content on the kinetics and end-state of
PEG:dextran network formation (indicated via gelation time and bulk stiffness) and
adhesive reactivity with tissue (indicated via burst pressure, retained lumen area and
SLS equilibrium arm stiffness Ke) are indeed limited and roughly characterized by a
sensitivity threshold as CHO:NH 2 exceeds 3.
The plateaus of equilibrium arm stiffness Ke and sealant performance metrics (burst
pressure, lumen deformation) with increasing CHO:NH 2 suggests that dextran aldehyde
molecules enable gel integrity and tissue seal and are the limiting element in tissue-
material interaction. Sealant apposition to tissue can only occur if the aldehyde groups
react with both PEG nodes within the gel and tissue sites outside of the gel. The
concentration of aldehydes therefore determines the extent of internal gel cohesion and
external adhesion to tissue. At a critical CHO:NH 2, increasing dextran aldehyde
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molecules no longer promotes additional adhesive interactions, possibly owing to steric
hindrance of adhesive bond formation. If a clinical application requires more extensive
modulation of the above properties, concurrent adjustments of other compositional
variables within the PEG:dextran system (for example PEG solid content) will likely be
required to compensate for steric effects.
Molecular engineering of PEG:dextran stress relaxation mechanisms could augment
aldehyde-mediated adhesion to tissue and improve failure resistance of tissue-material
interfaces. Polymer chain mobility and hence stress relaxation could be manipulated
through the molecular length of constituent dextran and the grouping of aldehydes along
a dextran chain. Longer chains with more distant reactive sites should possess greater
molecular mobility and thus entropically dissipate greater amounts of strain energy.
Such a material design strategy is distinctly different from simply increasing aldehyde
content to improve adhesive strength at the expense of an unfavorable tissue response,
an approach which would essentially conform to the established limitations of sealant
technologies.
Traditional tissue adhesives and their associated limitations have raised the need for
an alternative adhesive system with tunable bioreactivity. Herein we have identified
PEG:dextran as a soft tissue adhesive which can be functionally modulated through the
constituent aldehyde content. The adhesive mechanical model we utilized relates
PEG:dextran chemistry to tissue-material interactions and overall performance. In this
specific case the model suggests that viscoelastic adhesion can improve the efficacy of
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these and other polymeric sealants. In general such a melding of empiric and modeling
approaches may continue to aid in rational application- and tissue-specific material
design.
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3.2.6 Conclusion
The efficacy of soft tissue sealants is limited by sub-optimal extremes of bioreactivity
and adhesion strength characteristic of available materials. PEG:dextran hydrogels
viscoelastically adhere to tissue to a controllable extent and demonstrate great potential
to address current clinical needs. Through systematic analyses of material formulations
with graded levels of aldehyde content, we show that PEG:dextran adheres to intestinal
tissue largely based on aldehyde-mediated reactivity with the capability to relax stress in
the presence of sustained strain. A viscoelastic solid model of adhesive mechanics
suitably represents the mechanical properties of tissue-material test elements formed
with PEG:dextran and other traditional sealants. Incorporation of PEG:dextran
compositional information into the model provides a design tool for strategic adjustment
of material composition based on application requirements. Through correlation
analyses between pertinent sealant performance metrics and viscoelastic model
descriptors, the exploitation of stress relaxation emerges as a potential means of
increasing interfacial failure resistance following adhesive applications to soft tissue.
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3.2.7 Study Transition
Study 2 reveals the importance of maintaining native tissue viscoelasticity following
adhesive interactions and insomuch suggests a material design principle applicable to
all implants which intimately interact with soft tissue. However, aldehyde-mediated
adhesion and tissue response was assessed with a single tissue type (duodenal) which
represents only one of the possible target anastomotic sites for clinical sealant
applications. We foresee natural soft tissue variability (biochemical, mechanical, etc.)
among potential sealant targets as a complication in generalizing the proposed design
strategy to other targeted tissue beds or new biomaterial systems. Target tissue
mechanics will define the desired native viscoelasticity while local biochemistry may
modulate susceptibility to aldehyde-mediated adhesion. To substantiate the notion of
tissue-specific effects, we next analyze adhesion between PEG:dextran and a range of
soft tissues (duodenal, heart, lung, liver) and seek a mechanistic basis for emergent
differences.
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Publication disclosure
The following presentation of Study 3 is based on:
Aldehyde-amine chemistry enables modulated biosealants with tissue-specific adhesion.
Artzi N, Shazly T, Baker A, Bon A, Edelman ER.
Advanced Materials 2009
3.3.1 Abstract
Bioreactive hydrogels featuring aminated star polyethylene glycol and high
molecular weight dextran aldehyde polymers (PEG:dextran) possess readily tunable
compositional variables that elicit control over both network formation and tissue-
material interactions. Previous studies comparing PEG:dextran to traditional soft tissue
sealants suggest these materials have potential to address clinical needs owing to
sufficiently high adhesion strength with an acceptable tissue response. Though all
candidate sealants rely on intimate tissue-material interaction for functional adhesion,
target tissue properties have been largely ignored in material design. Instead, one
general formulation is proposed for application to the full range of soft tissues across
diverse clinical applications. Here we demonstrate that aldehyde-mediated adhesion to
tissue strongly depends on target tissue type and propose a rational approach for the
engineering of application-specific surgical sealants.
Page 103 of 189
TISSIIFISPEC1IFIC L~DHESION_? _? STllnv R
3.3.2 Introduction
Hydrogels consisting of aminated star polyethylene glycol and high molecular weight
dextran aldehyde polymers (PEG:dextran) possess a predictable range of cohesive and
adhesive properties [47, 50, 70]. The cohesive integrity of PEG:dextran is derived from
imine bonds that form through a Schiff base reaction between constituent amines and
aldehydes. When crosslinked on soft tissue surfaces, aldehydes not consumed in bulk
network formation can participate in analogous bonds with tissue amines to attain
adhesion. Aldehydes in excess of what is required for cohesion or adhesion can induce
tissue toxicity. Consequently, aldehyde density is the key material design parameter for
informative evaluation of both tissue-material adhesion and tissue response. Here we
demonstrate that the natural variation of amine density among multiple soft tissues will
have a parallel influence on tissue-material interactions and form a basis for tissue-
specific material design.
We designed and evaluated a series of PEG:dextran formulations featuring low
(8.8%, L-PD), medium (14.0%, M-PD), and high (20.0%, H-PD) levels of dextran
aldehyde solid content. Additional design parameters, including dextran molecular
weight (10 kDa), dextran oxidation state (50%), and PEG amine solid content (25%),
were identical among formulations and selected to provide stable and bioreactive
networks for evaluation of adhesive interactions. We demonstrate that physical and
mechanical aspects of PEG:dextran adhesion are tissue-specific and can be readily
adjusted through manipulation of material aldehyde content. Because adhesion is
mediated through material crosslinking to local tissue amines, judicious modification of
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formulation aldehyde content is a logical approach to ensure sufficient adhesion
strength for a given clinical scenario.
Aldehyde-mediated adhesive design is complicated by significant biochemical
variations among soft tissues. We examined the surface amine group densities in
biopsy samples of rat cardiac, lung, liver, and duodenal tissue and correlated
biochemistry to PEG:dextran adhesion. Mechanical and biochemical data clearly
demonstrate the influence of target soft tissue type on the outcome of aldehyde-
mediated interactions. The need for careful titration of material composition is reiterated
by the in vivo tissue response to PEG:dextran, as local inflammation is also influenced
by material aldehyde density. These concepts define a therapeutic window for optimal
tissue-sealant interactions, bounded below by the need for adequate adhesion strength
and above by the condition of biocompatibility.
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3.3.3 Materials and Methods
PEG:dextran composition
The synthesis of star PEG amine and dextran aldehydes as well as PEG:dextran
network formation have been previously described [14-17]. Briefly, eight-arm 10 kDa
star PEG polymer with amine end groups was dissolved in water to form a 25 wt. %
aqueous solution. Linear dextran (10 kDa) was oxidized with sodium periodate to yield
dextran aldehyde, which was also prepared as an aqueous solution (8.8 - 20.0 wt. %).
The polymeric constituents of PEG:dextran were prepared as minimally viscous
aqueous solutions and consistently polymerized through injection from a dual chamber
syringe equipped with a mixing tip. The present study examines the effect of aldehyde
content on adhesion strength and tissue response, motivating the design and synthesis
of a series of materials with isolated variation in dextran aldehyde solid content.
Subcutaneous Mouse Model
A subcutaneous implantation model of tissue response was used to evaluate
material biocompatibility in vivo. A subcutaneous pocket was created in anesthetized
C57BL/6 mice and PEG:dextran (200 pII) was injected into the pocket using a dual
chamber syringe equipped with a sterile mixing tip. After 9 days, the mice were
sacrificed and the skin and subcutaneous tissues were harvested. The samples were
snap frozen in liquid nitrogen and stored at -80 OC until histological and zymographic
analyses. All experimental protocols were approved by the MIT Animal Care and Use
Committee and were in compliance with NIH guidelines for animal use. Harvested
tissue was sectioned using a cryotome to create 20 pm thick sections. Hematoxylin and
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eosin staining was performed using standard methods. Fibrotic response was based on
morphology and measured in multiple random locations in five images from tissue
samples from each mouse. Zymography was performed using quenched fluorescein-
labeled gelatin and quantified using Adobe Photoshop as previously described [21].
Fluorescent PEG amine
To characterize the PEG:dextran morphology at the tissue-material interface as well
as track gradual material release from the tissue surface, constituent PEG amine was
labeled with fluorescein. PEG amine (2.4 g) was dissolved in 6 mL dichloromethane,
followed by the addition of 0.015 g 6-(fluorescein-5-carboxyamido) hexanoic acid
(Invitrogen) and 12 pL triethylamine (Sigma). The mixture was stirred at room
temperature for 48 hours. The resulting solid after solvent evaporation was dissolved in
100 mL water, dialyzed and lyophilized. PEG amine solutions of 25 wt. % solid content,
0.5 % of which were fluorescently labeled, were then prepared and crosslinked with
dextran aldehyde solutions in the established manner yielding fluorescent materials.
Adhesion mechanics
The adhesion mechanics following PEG:dextran application to soft tissues was
measured with monotonic uniaxial tensile testing (Bose® Biodynamic Test Instrument,
Minnetonka, MN). Adhesive test elements were created from a 200 pl application of
PEG:dextran evenly distributed between two uniformly sized tissue biopsies (disks of 8
mm diameter, total test element thickness of 1 mm) of rat duodenum, heart, lung or
liver. Tissue surfaces were gently dried prior to material application. After applying
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PEG:dextran between tissue surfaces and allowing five minutes for material
polymerization, adhesive test elements were displaced at a constant rate (0.05 mm/sec)
and the load response was continuously recorded (200 measurements/sec). Recorded
loads were normalized by test element cross-sectional area and reported as an
interfacial stress response to a change in thickness.
Adhesive interface morphology
PEG:dextran morphology following adhesion to various soft tissues was assessed
with quantitative microscopy. Uniform biopsies from freshly harvested rat lung, liver,
heart, and duodenum provided a controlled surface area (20 mm 2) for material
application. Fluorescently labeled PEG:dextran (50 pl) was applied to tissues after blot
drying and allowed to fully polymerize. Tissue samples were then cryosectioned (20 Pm
sections) and stained with rhodamine phalloidin (Invitrogen) and DAPI (Vector
Laboratories). PEG:dextran morphology at the tissue-material was quantified using
image analysis techniques (Leica Microsystems, MetaMorph®) to characterize the
transitory material between tissue surfaces and material bulk. Please see appendix for
additional detail (A9 Morphological Analyses of Adhesive Interface).
Aldehvde affinity of soft tissue surfaces
To determine the aldehyde affinity of various soft tissues, the conjugation of
aldehyde-coated fluorescent microspheres (Molecular Probes) to soft tissue surfaces
was quantified. Biopsies of rat lung, liver, heart, and duodenum were prepared with
equal surface area (20 mm 2) and submerged in 0.5 ml of 0.5 % f-MS solutions for 20
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minutes on rocker at 372C. Tissue samples were thoroughly rinsed with 10 ml PBS
three times. Tissue specimens were then processed and analyzed to quantify the
percent surface coverage by f-MS (Leica Microsystems, MetaMorph@). Please see
appendix for additional detail (Al 0 Fluorescent Microspheres)
Material retention
To track material loss following PEG:dextran adhesion to various soft tissues,
fluorescently labeled materials were applied to lung, liver, heart and duodenum biopsies
(4 mm disks). Identical volumes (200 pl) of PEG:dextran (14 % dextran aldehyde
variant, L-PD) were applied to tissue surfaces and allowed to polymerize for five
minutes. Samples were then submerged in PBS at 37 2C for four hours. The fluorescent
signal (485 nm excitation and 538 nm emission) accruing in the media was periodically
monitored throughout the suspension period to assess the kinetics of material
dissociation from the tissue.
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3.3.4 Results
In vivo tissue response
The in vivo tissue response to subcutaneous implants was used to evaluate the
biocompatibility of PEG:dextran materials and particularly the influence of aldehyde
content on tissue response. PEG:dextran variants (L-PD, M-PD, and H-PD) were
implanted into a subcutaneous pocket in mice which were then survived for nine days.
Inflammation as manifest by thicker fibrous capsule rose with aldehyde content (Figure
37). Inflammatory cell-mediated proteolysis affects wound repair as matrix
metalloproteases cleave the extracellular matrix weakening the tissue and surgical
anastomoses. The gelatinase activity in the tissues, measured using analytical
fluorescent microscopy and in situ zymography, also increased with material aldehyde
content (Figure 38). This trend in proteolytic activity is likely a result of the increased pro-
inflammatory mediators and activation of polymorphonuclear leukocytes generated by
the reactive aldehyde groups.
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Figure 37 Tissue reactivity in-vivo was assessed for subcutaneous implants of materials having
low (8.8 wt. %), medium (14.0 wt. %) or high (20.0 wt. %) dextran aldehyde solid content.
Histomorphometric analysis reveals increased fibrotic capsule thickness and inflammatory cell
presence in materials with high aldehyde content. (* p < 0.05 compared with 14.0% solid content).
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Figure 38 Tissue reactivity in-vivo was assessed for subcutaneous implants of materials having
low (8.8 wt. %), medium (14.0 wt. %) or high (20.0 wt. %) dextran aldehyde solid content.
Gelatinase zymographic activity was increased with material aldehyde levels. (* p < 0.05 compared
with 14.0% solid content).
Adhesion mechanics
Adhesion mechanics were measured ex vivo with soft tissues harvested from rats
(adult Sprague-Dawley, Charles River Laboratories, MA) immediately after animal
sacrifice (under university IACUC protocol and federal guidelines for animal care).
Adhesive test elements were constructed with biopsy specimens of uniform thickness (1
mm) from heart, lung, liver, and duodenal tissues to facilitate uniaxial mechanical testing
of tissue-material interfaces. The stress response of adhesive test elements over a
range of applied displacement varied with material aldehyde content and tissue type
(Figure 39).
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Figure 39 The adhesion of PEG:dextran-based adhesives depends on tissue type (heart, lung,
liver, or duodenal rat biopsies) and constituent chemistry, evaluated at low (A, 8.8 wt. %), medium
(B, 14.0 wt. %) or high (C, 20.0 wt. %) concentrations of dextran aldehyde solid content.
Interfacial moduli were calculated from the initial stress response (1 < interfacial
thickness < 1.05) to allow for succinct comparison of adhesive mechanics (Figure 40). The
modulus of H-PD adhesion to duodenal test elements (724 ± 86 kPa) was significantly
greater (p < 0.001) than lung (72 ± 7 kPa), while heart and liver moduli were
comparatively intermediate (296 ± 60, 431 ± 15 kPa, respectively). The extent to which
aldehyde content altered adhesive stiffness is markedly tissue-specific. Cardiac tissue
test elements exhibited the greatest relative increase in interfacial stiffness when
comparing L-PD and H-PD variants (1785 %), while lung tissue had a much weaker
dependence (283 %). Overall, these data support the notion that both tissue type and
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material chemistry influence aldehyde-mediated adhesive interactions, providing a
functional basis for tissue-specific sealant design.
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Figure 40 The moduli of the adhesive test elements increased with
aldehyde content dependant on tissue type.
Adhesive interface morpholoav
The interfacial regions between PEG:dextran and excised rat cardiac, lung, liver and
duodenal tissues were physically analyzed with fluorescent microscopy. Three distinct
domains were evident upon material adherence, including the target tissue, bulk
material, and an adhesive regime interposed between the two (Figure 41). The adhesive
regime depicts the intermediate material structure resulting from concurrent dextran
aldehyde reactivity with PEG and tissue amines. The morphology of the adhesive
regime varied with tissue type, appearing fibrillar and discontinuous on cardiac and lung
tissues, and more continuous and intact over liver and duodenum. Quantitative
microscopic evaluation of the adhesive regimes based on fluorescent material intensity
Page 113 of 189
provides normalized metrics of area per unit interfacial length (adhesive regime size)
and the material concentration (adhesive regime density). Significant differences in the
resultant PEG:dextran morphology were measured following tissue-material adhesion
(Figure 42). While the adhesive regime above duodenal tissue was minimal in size (0.24 +
0.11) and comparatively dense (1.27 ± 0.17), interactions with heart, lung, and liver
yielded more expansive and disperse adhesive interfaces. Comparisons between
adhesive morphology and mechanics confirmed common physical intuition, as both
adhesive regime metrics strongly correlate to interfacial moduli (IRI = 0.95, p < 0.05, L-
PD variant) across tissue types, indicating that small and dense material transitions
between tissue and bulk yield stiff adhesive interactions.
Figure 41 The interface between PEG:dextran (green) and various
soft tissues, highlighted with rhodamine phalloidin (actin, red) and
DAPI (cell nuclei, blue), varies with tissue.
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Figure 42 Interfaces with PEG:dextran with excised soft tissues exhibit a
range of adhesive regime area (size normalized to interfacial length) and
density (fluorescence intensity), Indicating that adhesion is modulated by
tissue type.
Aldehyde affinity of soft tissue surfaces
The conjugation of aldehyde-coated fluorescent microspheres (f-MS) to soft tissues
was used to probe tissue surface chemistry and provide a mechanistic basis for the
demonstrated variability in adhesive interactions. Tissue biopsies of controlled surface
area were excised from rat heart, lung, liver and duodenum and allowed to react with f-
MS through gentle mixing in an aqueous solution. Following suspension, the fluorescent
intensity at the surface of the tissue samples was quantified to generate an aldehyde
conjugation metric reflecting the percent of tissue surface coverage by immobilized f-MS
(Figure 43). The conjugation metric is indicative of the aldehyde affinity of soft tissues and
provides a fairly direct measure of the targeted biochemistry for PEG:dextran adhesion.
Soft tissues display a range of f-MS conjugation metrics, with duodenal tissue
possessing the greatest apparent aldehyde affinity. Comparison of tissue conjugation
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metrics to adhesive mechanical data parenthetically supports aldehyde-mediated
adhesion, as interfacial moduli strongly correlate (R = 0.92, p < 0.05) to aldehyde affinity
across tested tissue types and material variants. The aldehyde content of materials and
aldehyde affinity of tissue seemingly present a mechanism by which to design and
select materials based on clinical applications. Please see appendix for additional detail
(A10 Fluorescent Microspheres).
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Figure 43 The relative aldehyde reactivity of heart, lung, liver and duodenal
rat tissue were assessed though tissue sample conjugation of fluorescent
aldehyde-coated microspheres. Aldehyde reactivity was lowest in the lung
and heart, greater in the liver and highest in the duodenum (* p < 0.05
compared with all other tissues).
Material retention
The extent of tissue-material interaction should largely determine the tissue retention
of an adhesive material. Fluorescent PEG:dextran materials were applied to tissue
biopsies and submerged in media under defined conditions. The presence of released
fluorescent signal was monitored as the media was periodically changed. This signal is
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a surrogate for the effective material loss from a tissue surface and varied based on
underlying tissue type. Relatively rapidly fluorescent accumulation occurred when
PEG:dextran was applied to heart and lung tissue, while hepatic and duodenal
specimens exhibited protracted release kinetics (Figure 44). PEG amine content lost to the
media evidentially depends on the material continuity at the tissue surface, as
significant correlations of cumulative material loss to adhesive regime size and intensity
(IRI > 0.90, p < 0.05) were found across tissue types.
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Figure 44 Differential adhesive retention was seen when applied to different
tissues. Adhesive is most stable when applied to the duodenum while
those applied to the liver, lung and heart degrade faster and at an
increasing rate.
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3.3.5 Discussion
Soft tissues provide a range of biological functions within diverse environments.
These readily observable differences suggest that natural biochemical variability also
likely exists among soft tissue surfaces. In this work we demonstrate that the apparent
amine content on tissue surfaces indeed depends strongly on tissue type. Duodenal,
cardiac, hepatic, and pulmonary tissue, all of which are potential targets for clinical
sealants, span an approximate six-fold range in surface amine content. We sought to
determine the feasibility of designing tissue-specific sealants which draw on this
biochemical variance to improve upon the performance of currently used materials.
The clinical need to control tissue-sealant interaction is evident, as available
materials fail to strike an optimal balance between sufficient adhesion strength and
limiting tissue response. The bioadhesive hydrogel PEG:dextran primarily interacts with
soft tissues via material aldehyde-tissue amine bond formation, and thus is an ideal
probe of tissue-specific adhesion in a series of tissues with different target group
densities (amine groups). Variations in tissue type and PEG:dextran aldehyde content
were both seen to modulate the mechanical stiffness of adhesive constructs ex vivo, as
indicated by the defined adhesive moduli. Tissue type also influenced the physical
integrity of adhesive interfaces and material retention time subsequent to PEG:dextran
application to biopsy specimens. When viewed in combination, mechanical and physical
data suggest tissue chemistry regulates the strength and duration of PEG:dextran
bioadhesion.
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Much like adhesive interactions, PEG:dextran biocompatibility is also aldehyde-
mediated. Material formulations with high aldehyde content induced the most severe
tissue response according to multiple markers of inflammation. The tissue response
was assessed in a subcutaneous model which offers no information on a tissue-specific
inflammatory response. Although this can be viewed as a limitation of the present study,
we believe that inflammation is a largely consistent biological process throughout the
body, implying that excess aldehyde will reduce PEG:dextran biocompatibility in all soft
tissue beds.
The data generated presented herein gives credence to tissue-specific adhesion and
can guide the development of aldehyde-mediated clinical sealants. For example, where
tissues are less responsive to changes in PEG:dextran aldehyde content, as in the case
of lung, aldehydes might simply be provided at some minimal level with an anticipated
limitation in adhesion strength and implant duration. In the other tissues, where
aldehyde affinity is higher and resultant adhesion more responsive to material
chemistry, one may consider designing compositions for extended duration and desired
adhesion strength to meet application requirements. The notion of tissue-specific
adhesion has momentum for clinical sealant development, but additional work is needed
go beyond providing guidelines and actually optimize PEG:dextran or other material
formulations to maximize therapeutic benefit with acceptable tissue response.
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3.3.6 Conclusion
Aldehyde-presenting PEG:dextran materials exhibit tissue-specific adhesive
properties. However, the benefit of increased adhesion of materials with greater
aldehyde content must be balanced by adverse biologic responses to excess free
aldehydes. Substantial difference in soft tissue aldehyde affinity shifts the balance
between adhesion and inflammation for each tissue and suggests that a class of
materials could be optimized for specific needs. Though tissue surface chemistry is an
often ignored it is a critical determinant of tissue-material interaction and must be
considered in future attempts at adhesive optimizations. Unlike cyanoacrylate and fibrin
glue, PEG:dextran based materials have flexible design parameters that enable their
mediation for specific application. Quantification and consideration of tissue properties
must be a part in the design of any adhesive material to advance material selection for
the full range of target tissues and clinical needs. The performance of existing and
future adhesive materials should be examined with regard to tissue specificity.
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3.3.7 Study Transition
As underlying theme of this work is the functional benefit of approximating soft tissue
composition with a hydrogel-based adhesive system. The biocompatibility conferred by
highly swellable materials is well documented in other systems and also observed in
PEG:dextran, particularly the less bioreactive material formulations. However, we fully
expect some reduction in functional potential as a consequence of material swell. As
material swell induces a volumetric expansion at the tissue-material interface, a loss of
adhered material density may compromise adhesive strength and failure resistance of
PEG:dextran sealants. We next assess the significance of a swell-induced property loss
in PEG:dextran, and seek material design solutions to enhance the sealant functional
potential throughout the course of inevitable swell in-situ.
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3.4.1 Abstract
Soft tissue sealants are routinely used in surgical procedures despite limitations of
insufficient adhesion or excessive local inflammation. In this study, we apply an
emergent biomimetic strategy to modulate the wet adhesion of a candidate hydrogel-
based sealant and assess the coupled effect on material biocompatibility. Marine
mussels provide a natural model for sealant design as they adhere to various surfaces
under considerable hydrodynamic forces. A major component of marine mussel
adhesion plaques is the modified amino acid 3, 4-dihydroxy-l-phenylalanine (DOPA).
We applied DOPA conjugation to functionally enhance a two-component hydrogel
sealant composed of aminated star polyethylene glycol and linear dextran aldehyde
polymers (PEG:dextran). Covalent incorporation of 0.3 wt. % DOPA into the
PEG:dextran network significantly improved adhesive interfacial integrity and bursting
strength of repaired duodenal wounds following hydration. Furthermore, functional
DOPA levels did not drastically exacerbate the in vivo tissue response to subcutaneous
PEG:dextran implantations as measured by local formation of a fibrous layer,
inflammation and stimulation of matrix metalloprotease activity. Taken together, these
data support DOPA conjugation as a promising approach to augment hydrogel-based
sealant performance without compromising biocompatibility.
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3.4 STUDY 4 THE EFFECTS OF MATERIAL SWELL ON ADHESION
3.4.2 Introduction
The bioadhesive properties of soft tissue sealants provide a range of potential
therapeutic opportunities [6, 8, 17]. Sealant adhesion results from in-situ polymerization
initiated by tissue constituents such as trace water and calcium ions in cyanoacrylate
derivatives and fibrin glues, respectively [17, 71]. Sealants form external adhesive
bonds with tissue elements and internal cohesive bonds with self to control tissue-
material interfacial and bulk material properties, often in a linked manner.
Cyanoacrylate-based materials are relatively stiff and bind avidly to tissue, while more
compliant fibrin glues exhibit comparatively limited adhesion [7, 14, 56]. Although the
operative chemistries vary between traditional materials, individual sealants make use
of the same type of chemical reaction to create both adhesive and cohesive bonds, thus
promoting continuity between the interstices of the material bulk and the tissue-material
interface. For all materials, the extent and nature of adhesive crosslinking, bulk
properties, the biological response, and degradation kinetics cumulatively define sealant
performance [20].
Despite a sustained developmental effort spanning over 50 years, no available
material meets the full range of clinical needs [8, 18]. Sealant performance is generally
bounded by deficiencies stemming from low adhesion strength or excessive tissue
inflammation and likely reflects inadequate reactive chemistry on the one hand and the
lack of directed tissue-material interactions on the other [13]. To address these issues, a
two-component hydrogel composed of amine-functionalized star polyethylene glycol
and dextran aldehyde polymers (PEG:dextran) was proposed as an aldehyde-mediated
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adhesive with tunable functional properties [45, 46, 70]. PEG:dextran hydrogels are
crosslinked by imine bonds between constituent amines and aldehydes. An analogous
chemistry governs the primary PEG:dextran adhesive mechanism wherein free hydrogel
aldehyde groups bind to amine groups on the tissue surface. We have previously
demonstrated that rational adjustment of formulation reactive group concentrations can
control of both adhesive and bulk material properties in the PEG:dextran system .
Persistent sealant adhesion to tissues under physiologic loading implies that overly
stiff materials will generate local stress concentrations at the tissue-material interface.
Excessive interfacial stress can destroy underlying tissue architecture and compromise
material integrity [70, 72]. Thus, an ideal sealant would match tissue compliance to
minimize interfacial stress and limit the risk of adhesive failure. In this respect,
hydrogels are an attractive material class for sealant development as their mechanics
after swell are generally comparable to native soft tissue [58]. The characteristically high
water content of hydrogels also confers excellent biocompatibility, providing further
impetus for their use as implantable biomaterials [73-75].
While hydrogel swell is beneficial to interfacial mechanics and biocompatibility, bulk
material expansion may reduce sealant functionality. Here we demonstrate that the
adhesive interface between PEG:dextran and duodenal tissue is physically altered and
functionally compromised as a result of material hydration ex vivo. We adopt a
biomimetic design strategy to mitigate swell-induced functional loss, particularly the
conjugation 3,4-dihydroxy-l-phenylalanine (DOPA) to the PEG:dextran network. DOPA
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has been recognized as a key amino acid governing the remarkable wet adhesion
capabilities exhibited by marine animals, and has been successfully used as a tissue-
reactive element in other material systems [76-79].
When incorporated into the PEG:dextran network, DOPA counterbalances swell-
induced property loss as indicated by the burst pressure of repaired intestinal wounds in
an ex vivo model of sealant performance. DOPA conjugation also minimizes the swell-
induced reduction of PEG:dextran integrity near the tissue-material interface, with
observable modulation of network continuity in 0.3 wt. % modifications. Significant
correlation (R = 0.92, p < 0.05) between retained adhesive network integrity and ex vivo
burst pressure after swell reiterates the importance of intrinsic material response to
hydration. The in vivo tissue response to a series of modified PEG:dextran implants
demonstrates that material biocompatibility is largely maintained at functionally effective
DOPA levels, although higher concentrations induce significantly greater inflammation.
Incorporating DOPA into the PEG:dextran bulk is a promising design strategy to safely
enhance soft tissue sealant performance, and is likely applicable to other hydrogel-
based adhesives.
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3.4.3 Materials and Methods
Material synthesis
The syntheses of star PEG amine and linear dextran aldehyde polymers along with
PEG:dextran copolymerization have been previously described [45, 46]. Briefly, eight-
arm, 10 kDa star PEG polymer with amine end groups was dissolved in water to form a
25 wt. % aqueous solution. Linear dextran (10 kDa) was oxidized with sodium periodate
to produce dextran aldehyde polymer (50% oxidation of glucose rings, two aldehyde
groups per oxidized glucose ring), which was prepared as an 8.8 wt. % aqueous
solution. Polymeric constituents spontaneously react to form a hydrogel following a
volumetrically-balanced injection from a dual-chamber syringe equipped with a 12-step
mixing tip. The PEG:dextran network crosslinks are derived from reaction between the
constituent aldehyde and amine groups through a Schiff base intermediate.
Variations of both PEG:dextran network constituents were used in this work,
specifically fluorescein-labeled PEG amine (FITC-PEG) and DOPA-modified dextran
aldehyde. In order to synthesize FITC-PEG, star PEG amine (2.4 g) was dissolved in
dichloromethane (6 mL), followed by the addition of 15 mg 6-(fluorescein-5-
carboxyamido) hexanoic acid, succinimidyl ester (Invitrogen) and 12 pL triethylamine
(Sigma). The mixture was continuously stirred at room temperature for 48 hours. The
resulting solid after solvent evaporation was dissolved in 100 mL water, dialyzed against
4 L of water (Spectra/Por Biotech Cellulose Ester dialysis membranes, MWCO 500,
Spectrum Laboratories) and lyophilized for 48 hours (-46-C, 3x10 3 mbar). FITC-PEG
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solutions of 25 wt. % solid content, 0.5% of which were fluorescently labeled, were used
for co-polymerization with dextran aldehyde solutions.
A series of modified polymers was created by mixing various masses of DOPA
(Sigma) with dextran aldehyde solutions (20 mL) for 3 hours at 602C. After mixing,
homogeneous solutions were dialyzed for 24 hours against 4 L of water (as above).
Solutions were snap frozen in liquid nitrogen and lyophilized (as above). Dehydrated
solid was recovered and reconstituted in water to yield DOPA-modified dextran
aldehyde polymer solutions.
Material characterization: DOPA coniugation to dextran aldehyde
Hydrogen NMR was used to determine the extent of DOPA conjugation to dextran
aldehyde. A series of homogeneous DOPA and dextran aldehyde solutions were
prepared in D20 as described above (without solution dialysis) with initial free DOPA
concentrations of up to 12 wt. %. Pure DOPA and dextran aldehyde solutions were also
prepared for comparative analyses. NMR spectra were recorded (Bruker Avance 400
MHz instrument) and chemical shifts were reported in ppm relative to the deuterated
solvent.
Functional mechanical testing: ex vivo bust pressure
Adult Sprague-Dawley rats (250 - 300 g, Charles River Laboratories, MA) were
sacrificed by carbon dioxide asphyxiation under university IACUC protocol and federal
guidelines for animal care. The duodenum was excised and immersed in 10 ml Krebs-
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Henseleit buffer at room temperature. Longitudinal duodenal segments were cut and
inserted into a mechanical testing apparatus capable of controlled luminal perfusion
(Bose@ Biodynamic Test Instrument, Minnetonka, MN). A wound was introduced by full-
thickness puncturing of the intestinal wall with an 18 gauge needle. Wounds were then
repaired with 200 pl application of PEG:dextran to the outer intestinal surface. A five
minute sealant curing time was allowed, after which intestinal samples were submerged
in PBS for up to one hour. The burst pressure of repaired intestinal wounds was
measured through gradual increase of lumen pressure developed through restriction of
flow (50 ml/min) distal to the sample lumen. Failure of the wound repair site resulted in
an immediate loss of luminal pressure and visible PBS leakage at the tissue-material
interface. The maximum luminal pressure prior to interface failure indicates the wound
burst pressure [70].
Interfacial integrity
The interfacial integrity of PEG:dextran adhered to excised rat duodenal tissue
(harvested as above) was quantitatively assessed after sample hydration treatments of
up to one hour. Material formulations (200 pl) featuring FITC-PEG were applied to the
serosal surface and allowed to polymerize for five minutes prior to sample hydration.
Following submersion in PBS for the designated swell times, samples were snap frozen
in liquid nitrogen, cryosected (20 pm thick sections), and stained with DAPI mounting
medium (Vector Laboratories) in accordance with standard protocols. Sections were
imaged with a fluorescent microscope (Leica) at 200x magnification with optical filters
amenable to FITC-PEG and DAPI emission/absorption spectra. Image analyses
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software (MetaMorph) was used to overlay corresponding images and depict the
interfacial region between PEG:dextran and duodenal tissue. The linescan software
feature was used to quantify the fluorescent signal from FITC-PEG in the first 500 pm
extending normally from the serosal surface. The average fluorescent signal from 3-5
linescans per image reflects PEG:dextran integrity at the adhesive interface.
Biocompatibility: in vivo tissue response
The biocompatibility of PEG:dextran adhesives was evaluated by the local tissue
response to subcutaneous implants in mice. Briefly, a pocket was created in the dorsal
subcutaneous space of anesthetized C57BL/6 mice and 200 pl of material was injected
into the pocket using a syringe with a sterilized mixing tip. After nine days, the mice
were sacrificed and the skin and subcutaneous tissues at the implantation site were
harvested. Tissue samples were frozen in liquid nitrogen and stored at -80-C until
histological analyses. All experimental protocols were approved by the MIT Animal Care
and Use Committee.
Harvested tissues were cryosected into 20 um sections and stained with
hematoxylin and eosin using standard methods. Light microscopy at 100x magnification
was used to assess the local fibrotic response in three randomly selected locations on
each tissue section and quantified by the fibrotic layer thickness (Adobe Photoshop).
Zymography was performed using quenched fluorescein-labeled gelatin and
fluorescence intensity was quantified and normalized to indicate relative enzymatic
activity (MetaMorph) [80]. Immunohistochemical staining for macrophages was
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performed as previously described [81]. Briefly, sections were blocked in 10% goat
serum for 40 minutes and incubated overnight with a primary antibody for Mac-3
(Biolegend). The samples were then washed three times with PBS and incubated with
an anti-rat antibody labeled with alexafluor-594 dye (Invitrogen). After two hours of
incubation, the samples were washed extensively and coverslipped in DAPI-containing
mounting media (Vector Laboratories). The fluorescent intensity from alexafluor-594 dye
was quantified and normalized to provide a metric of macrophage activity (MetaMorph).
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3.4.4 Results
Material characterization
Hydrogen NMR was used to capture the signature spectra of dextran aldehyde
(Figure 45), DOPA (Figure 46), and a series of DOPA-dextran aldehyde conjugates. A
diagnostic signal for the imine proton present in the conjugate form (8.3 ppm) was
integrated against the three aromatic protons of DOPA to determine the extent of
conjugation [82]. In a system exhibiting complete DOPA conjugation, a ratio of 3:1
between the integrals of the aromatic DOPA and imine bond peaks would be expected
and was found (Figure 47). Conversely, when conjugation is not complete and DOPA
exists in both free and conjugated forms, the integrals of the imine and aromatic peaks
reflect the relative amount of conjugation in the material system. The reaction efficiency
nonlinearly depended on reaction conditions when initial DOPA concentrations ranged
from 0.1 to 12 wt. %, with only 10.3 % conjugation in the most concentrated solution
(Figure 48). Four conjugates of dextran aldehyde polymers with initial DOPA contents
ranging from 0 to 6 wt. % were synthesized for evaluation in the remainder of this work
(Table 15).
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Figure 45 NMR spectra of dextran aldehyde, with inset showing molecular structure and ppm
region-of-interest for determination of imine bond density.
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Figure 46 NMR spectra of DOPA, with inset showing molecular structure and ppm region-of-
interest for determination of imine bond density.
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Figure 47 NMR spectra of 0.3 wt. % conjugation of DOPA to dextran aldehyde dextran aldehyde,
with inset showing the ppm region-of-interest for determination of imine bond density. Following
conjugation, the triplet peaks (6.6 to 6.9 ppm) indicate total DOPA content, while the imine peak
(8.3 ppm) was diagnostic of conjugated DOPA.
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Figure 48 The ratio between the integrals of the triplet and imine peaks was
used to calculate the extent of conjugation following reaction, with a 3:1
ratio indicating complete conjugation. The % of initial DOPA (A) and the wt.
% of conjugated DOPA in the modified polymers (m) are presented as a
function of initial DOPA concentration in solution to indicate the variation of
reaction efficiency and product.
Table 15 Compositional description of the DOPA modified dextran aldehyde polymers.
Constituent dextran aldehyde properties (molecular weight, oxidation state, and solid content)
were constant across material variants, while initial DOPA content ranged from 0 to 6 wt. %.
The resultant extent of conjugated DOPA was determined by hydrogen NMR.
Dextran aldehyde DOPA conjugation Reaction efficiency
Molecular Oxidation Solid content Initial DOPAcontent Conjugated DOPA Conjugated DOPA
weight (kDa) state (%) (wt. %) (wt. %) (wt. %) (% of initial)
10 50 8.8 0 0
10 50 8.8 0.3 0.3 100
10 50 8.8 2.0 0.8 40
10 50 8.8 6.0 1.1 18
Burst pressure of repaired duodenal wounds
The ex vivo burst pressure of repaired puncture wounds following swell signifies the
potential of adhesive sealants to mitigate tissue dehiscence or leakage in multiple
clinical scenarios. Intestinal samples were wounded, repaired with PEG:dextran
variants, and submerged in PBS for up to one hour. The failure resistance of wounds
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repaired with unmodified PEG:dextran monotonically diminished with swell, exhibiting a
39 ± 18% reduction in burst pressure following one hour hydration (Figure 49). The swell-
response of modified PEG:dextran was markedly different, as the measured burst
pressure of the 0.3% DOPA conjugate varied between 66 ± 6.7 and 77 ± 9.7 mmHg
with no discernable dependence on swell time. Higher DOPA concentrations also
stabilized initial wound burst pressure throughout hydration, although the diminished
overall performance of 0.8 and 1.1% conjugates compared to unmodified PEG:dextran
points to a loss of functional sealant potential with excessive doping. The reduction of
PEG:dextran failure resistance at higher DOPA concentrations may reflect an
interference with bulk network formation, a notion further supported by a substantial
protraction of material gelation times for these formulations (data not shown).
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Figure 49 The ex-vivo burst pressure of repaired rat duodenal wounds as a
function of sample swell time. Puncture wounds were repaired with
PEG:dextran formulations featuring 0 % (o), 0.3 % (e), 0.8 % (o), or 1.1 % (m)
DOPA and then submerged in PBS. Following the designated swell time,
sample lumens were perfused with PBS (50 mL/min) and gradually
pressurized. The pressure at which the wound site failed was recorded as
the burst pressure. Error bars represent 1 standard error of measurement (n
= 4).
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Interfacial integrity
The integrity of adhesive interfaces between PEG:dextran variants and excised
duodenal tissue was assessed as a function of swell time. Integrity was quantified via
the fluorescent intensity emitted from PEG:dextran featuring FITC-PEG, providing a
direct correlate to average material density at the adhesive interface. The differential
responses of the unmodified PEG:dextran and the 0.3% DOPA conjugate portray a
reduction of swell-induced disturbance in the modified network (Figure 50). Quantification
of PEG:dextran intensity in the interfacial vicinity indicates both a swell-induced loss of
unmodified network integrity and the significant mitigation of this loss with 0.3% DOPA
incorporation (Figure 51). Following one hour swell treatments, the measured network
integrity correlates well (R = 0.92, p < 0.05) with the burst pressure of repaired wounds
across PEG:dextran variants, highlighting the influence of tissue-material continuity on
sealant performance (Figure 52).
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Figure 50 The interfacial integrity between duodenal tissue (cell nuclei stained blue
with DAPI) and FITC-labeled PEG:dextran variants (green) varied as a function of
swell time. The interfacial integrity of unmodified PEG:dextran (upper panels)
visibly diminished with swell, while the 0.3% DOPA variant (bottom panels)
remained comparatively stable. Scale bar = 1000 pm and applies to all images.
Figure 51 The material integrity extending normally from the
tissue surface (500 pm) was assessed with analytical
microscopy and presented as a function of swell time (B).
Error bars represent 1 standard error of measurement (n = 4).
* indicates p < 0.05 determined by ANOVA with post-hoc
analysis when compared to 0 minute swell time for each
material.
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Figure 52 Linear correlation (R = 0.92, p < 0.05) between
sample burst pressure and interfacial integrity after swell
suggests that local loss of material reduces sealant
functional potential (data point descriptors reflect DOPA
content).
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Material biocompatibilitV
The efficacy of strongly adherent surgical sealants is often limited by associated
tissue response. The biocompatibility of PEG:dextran variants was examined through
subcutaneous material implantations in mice. Three indicators of the tissue
inflammation were assessed based on microscopic analyses of stained sections,
including the fibrotic layer thickness, enzymatic activity, and macrophage density.
PEG:dextran implants elicited a fibrotic response to an extent obviously dependent on
material DOPA content (Figure 53). The fibrous layer thickness incited by unmodified
PEG:dextran implantations was minimal (90 ± 40 pm), suggesting that the established
biocompatibility of material constituents (PEG and dextran) is largely maintained in this
adhesive system. DOPA conjugation up to 0.8% was associated with a slight increase
in fibrosis, with thicknesses of 280 ± 40 pm and 190 ± 60 pm in the less concentrated
PEG:dextran variants. The tissue response to 1.1% DOPA implants was an order of
magnitude more severe than to unmodified PEG:dextran (fibrotic thickness of 890 ± 70
pm ), demonstrating hydrogel biocompatibility is compromised with extreme network
modification (Figure 54).
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Figure 53 Tissue fibrous layer thickness local to PEG:dextran
variants increases with DOPA content. Mice were implanted
with material (200 pl) subcutaneously and tissues were
harvested after nine days. Hematoxylin and eosin stained
sections of tissue demonstrate increased cellular infiltration
and formation of fibrous tissue surrounding the implanted
material. Scale bar = 500 pm and applies to all images.
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Figure 54 Fibrous layer thickness was measured and found
to be significantly increased in 1.1% DOPA content materials.
Error bars represent 1 standard error of measurement (n = 4
to 5). * indicates p < 0.05 determined by ANOVA with post-
hoc analysis when compared to unmodified PEG:dextran.
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Inflammatory cell-mediated proteolysis impedes wound repair via matrix
metalloprotease (MMP) cleavage of extracellular matrix proteins. MMP activity is often
elevated during surgery and particularly problematic at surgical anastomoses because
of the potential to destabilize wound sites and facilitate tissue dehiscence [83, 84]. The
gelatinase activity in local tissues following PEG:dextran implantations was measured
using in-situ zymography (Figure 55). The fluorescent intensity indicative of gelatinase
activity monotonically increased in response to formulation DOPA content, suggesting a
stimulation of pro-inflammatory mediators and polymorphonuclear leukocytes by
bioreactive DOPA (Figure 56).
Figure 55 Analysis of gelatinase activity in subcutaneous
tissue following implantation of PEG:dextran variants. In-situ
zymography with an internally quenched FITC-labeled gelatin
substrate indicated. Scale bar = 1000 pm and applies to all
images.
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Figure 56 Increased DOPA content stimulated tissue
gelatinase activity (B). Error bars represent 1 standard error
of measurement (n = 4 to 5). * indicates p < 0.05 determined
by ANOVA with post-hoc analysis when compared to
unmodified PEG:dextran.
Macrophages migrate to implantation sites and serve numerous functions
associated with tissue inflammation, including the regulation of fibroblast activity,
secretion of MMPs, and phagocytosis of material debris [85, 86]. Fluorescent mac-3
labeling demonstrated that macrophages were present at various densities following the
implantation of PEG:dextran materials (Figure 57). The density of macrophages in local
tissues was low and statistically indistinguishable until the highest DOPA concentration
was used (Figure 58). Macrophage density was approximately six-fold greater in tissues
subjected to 1.1% DOPA implantations compared to unmodified PEG:dextran, which
again suggests that excessive DOPA content will substantially reduce material
biocompatibility.
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Figure 57 Macrophage infiltration (red by immunofluorescent
staining for Mac-3) varied among subcutaneous implantations
of PEG:dextran materials. Scale bar = 1000 pm and applies to
all images.
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Figure 58 Macrophage infiltration was quantified with
analytical microscopy and found to be increased in 1.1%
DOPA content materials. Error bars represent 1 standard error
of measurement (n = 4 to 5). * indicates p < 0.05 determined by
ANOVA with post-hoc analysis when compared to unmodified
PEG:dextran.
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3.4.5 Discussion
Soft tissue sealants are utilized in numerous clinical procedures and consequently
exposed to various physiological surroundings. The in-situ environment and material
properties of the employed sealant will together dictate tissue-material interactions and
determine overall clinical efficacy. The local hydration state and material hydrophilicity
constitute a tissue-material property pair that affects the rate and extent to which
biological fluids will permeate sealants and influence adhesive interactions. For
example, sealants will rapidly encounter fluids when used to attain hemostasis in cases
of severe bleeding. In other clinical scenarios, such as anastomotic augmentation
following gastrointestinal resection, sealant exposure to tissue exudates may occur
more gradually. Regardless of hydration kinetics, intrinsic material properties alone
define the in vivo equilibrium swell state, as hydrophilic or hydrophobic sealants will
ultimately incorporate more or less biological fluid into the material network,
respectively. To accurately predict the performance of swellable sealants, the effects of
hydration on tissue-material adhesive interactions must be considered.
Hydrogel-based sealants could potentially suffer swell-induced reduction in clinical
efficacy by various mechanisms, including a passive interfacial dissociation due to
material expansion. Soft tissues are relatively stable with regard to water content, but
applied sealants will expand continually until they too reach an equilibrium swell state.
Sealant volume expansion could physically disturb the tissue-material interface and
diminish adhesive failure resistance under physiological loading. Here, we demonstrate
that reduction of PEG:dextran integrity at the adhesive interface is a consequence of
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swell and correlates with loss of sealant functional properties ex vivo. Although
hydrogels are a biocompatible material class for sealant development, extreme swell
will likely reduce in vivo functional performance. Analogous phenomena are expected to
limit highly hydrophilic biomaterials across a range of clinical applications, motivating
the pursuit for techniques of hydrogel property enhancement under swollen conditions.
Nature often inspires engineering solutions to dilemmas of biomaterial design. In this
work we adopted a biomimetic approach to bulk PEG:dextran modification that was
previously used in other material systems. Reports on the effects of both surface and
bulk DOPA-based modifications have collectively demonstrated modulated interaction
with both organic and inorganic surfaces [78, 87-89]. Prior studies have found that
polyDOPA films can be applied through simple dip-coating and promote adherence to
surfaces of metals, ceramics, polymers, and various cell lines [89]. The observed
functional potential of DOPA is supported by the role of this amino acid in vigorous and
water-resistant adhesion of marine animals. Multiple variants of the adhesive foot
protein 3 in Mytilus californianus (Mcfp-3) have been implicated in marine mussel
adhesion, with all proteins containing DOPA-rich domains [90]. The presently examined
DOPA conjugate to dextran aldehyde further recapitulates mussel adhesive plaques in
which adhesive proteins are embedded within polysaccharide matrices to facilitate
flexibility and failure resistance at the point of contact with underlying substrates [91].
Our study found that limited DOPA content within PEG:dextran significantly
improved sealant functional performance after swell without sacrificing hydrogel
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biocompatibility. However, higher levels of DOPA content were detrimental to both
sealant function and biocompatibility. The local fibrotic response and macrophage
invasion were severely elevated following implantation of 1.1% DOPA conjugates as
compared to less concentrated material formulations. In situ zymographic analysis
demonstrated a monotonic increase in protease activity with DOPA content. The 1.1%
DOPA variant incited an - 15-fold escalation in enzymatic activity as compared to
unmodified PEG:dextran. The need to tailor DOPA content in PEG:dextran is manifest
by the local tissue response in subcutaneous implant models and should direct future
material design. Furthermore, the functional enhancement provided by DOPA is best
realized at low concentrations. Excessive DOPA content likely interferes with network
polymerization, providing further incentive to limit the extent of chemical modification in
PEG:dextran.
The mechanisms by which DOPA additive modulates the adhesive properties of
PEG:dextran and other material systems remain unclear, but some possibilities are
suggested by this work. Prior to swell treatments, low DOPA levels did not substantially
alter the metrics of PEG:dextran functional performance. Differential properties between
unmodified PEG:dextran and the 0.3% DOPA-PEG:dextran conjugate did however
emerge after swell and could conceivably stem from two basic mechanisms; either
direct modulation of the PEG:dextran network swell response and/or DOPA-mediated
adhesion to tissue surfaces in the presence of water. The former possibility was
explored through multiple comparative measurements of the elastic moduli of the
unmodified PEG:dextran and the DOPA conjugate, pre- and post-swell. After one-hour
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swell treatment, unmodified PEG:dextran underwent an approximately 85% reduction in
surface stiffness, while the conjugate was softened by only 50% (please see appendix
for experimental details, All Nanoindentation Experiment). Additional measurements of
material swell ratio and bulk elastic modulus as a function of hydration time further
suggest that DOPA is modulating the performance of PEG:dextran by limiting network
response to hydration, ultimately demonstrating that stable material properties better
maintain initial sealant performance (please see appendix for experimental details, A12
Swell Response of DOPA Conjugates).
Reducing the material swell response after adhesion could facilitate better
maintenance of initial interfacial stability and may explain the relatively enhanced
functional performance of DOPA-PEG:dextran conjugates. Such phenomena fit nicely
within the context of this thesis work as DOPA can optimize material cohesion by virtue
of potentially mitigating the reduction of material strength in aqueous media. In further
keeping with the focus on imine-based tissue-material interactions, DOPA may affect
material bioadhesion as this molecule represents a terminal node in the PEG:dextran
network and consequently alters available bioreactive node densities. Alternatively,
DOPA may form clustered hydrogen bonds to tissue entities via the hydroxlyated ring as
suggested by previous studies [79].
Biomaterials must be evaluated at physiologically-relevant states to understand their
true clinical potential. The environments in which soft tissue sealants are employed
differ as a consequence of their application in surgical procedures, with a range of pH,
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mechanical forces, and target tissue chemistries encountered in routine use [20].
However, common among all sealant applications is the eventual exposure of adhesive
interfaces to biological fluids. Hydrogels are appealing platforms for development of
implants which intimately interact with soft tissues because of their composition and
associated biocompatibility; yet high material swell magnifies the influences of hydration
on tissue-material interactions. DOPA-based hydrogel network modification can
effectively combat a clinically-relevant functional loss related to swell as exemplified in
PEG:dextran sealants. DOPA conjugation has been implemented both at material
surfaces and throughout the bulk in multiple material systems, with the presently
demonstrated preservation of biocompatibility and enhancement of function implying a
universal significance for the design of hydrogel-based biomaterial implants.
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3.4.6 Conclusion
It is recognized that the local physiological environment can modulate
biomaterial implants to an extent which diminishes their therapeutic potential. In-
situ swell of a hydrogel-based soft tissue sealant represents a biologically-
induced dynamic which may compromise interfacial integrity and clinical efficacy.
We demonstrate that PEG:dextran sealants suffer a swell-induced reduction of
material density at the adhesive interface with a correlated loss of function in an
ex vivo model. Conjugation of DOPA to PEG:dextran enhances the post-swell
sealant performance, an effect congruent with the established role of this amino
acid in the wet adhesion of both marine animals and other synthetic materials.
Functionally effective levels of DOPA within PEG:dextran did not substantially
alter material biocompatibility as indicated by the subcutaneous tissue response
to a series of material formulations. In general, DOPA-based modification
provides a means to safely enhance wet adhesive properties and as such is a
powerful approach to sealant design.
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4. Experimental Difficulties, Future Work and Thesis
Conclusion
4.1 EXPERIMENTAL DIFFICULTIES
Scientific research is often iterative, sometimes circular, and on fine occasion yields
interpretable results. Up to this point this thesis is a presentation of only the latter, but
describing the evolution of reported techniques may assist future researchers. In
particular, the methods employed for adhesion strength testing, in vitro cellular studies,
image analyses, and histology were initially impeded by the following technical
difficulties.
Adhesion strength testing: Two varieties of tissue-material elements were
constructed for mechanical testing of adhesion in this work. The test elements
described in Study 1 were advantageous in the sense that minimal material and tissue
were used for each experimental run and sample fixation within the mechanical testing
grips was relatively simple. Prior to arriving at the described method, it was difficult to
secure duodenal samples in standard tensile grips without damaging the tissue.
Threading the duodenal lumen with a solid, flexible tube proved crucial for test element
stability, and is likely applicable to other testing configurations. This methodology was
sufficient to differentiate between the ultimate adhesive strength of a range of materials,
but was not conducive to mechanical modeling primarily because of the nature of
contact between opposed tissue samples (point contact). The test elements utilized
throughout the remainder of this work (Studies 2 and 3) involved excising larger
sections of duodenal as well as other soft tissues with dermal punches. These samples
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were appropriate to stress analysis and mechanical modeling because of the well-
defined contact geometries following adhesive application (circular cross-sections). A
technical difficulty that had to be overcome with this arrangement was ensuring that the
contact area was as intended and not only relegated to the circumference of test
elements. This was achieved by modifying the tubular fittings over which the samples
were attached such that they were solid (no hollow bore) to prevent tissue collapse
toward the center during testing.
In vitro cellular studies: The cellular assays presented in Study 1 were conducted
after exposure of cultures to either material degradation products or small volumes of
bulk materials. Other work (not shown) was also conducted which involved the direct
exposure of cells in culture to larger volumes of materials. When performing these
experiments, the number of cells that could be assayed subsequent to material
exposure was greatly limited; a majority of the cells were actually beneath/within the
material and not readily extracted for analysis. Furthermore, using large volumes of
material interfered with the employed assays to an extent which could not be simply
accounted for with standard curves. To address these concerns, we utilized cell culture
inserts such that cells could share media with substantial material bulk without being
largely covered or engulfed. Although no in vitro data featuring the cell culture inserts is
presented in this thesis, this approach was successful in reducing material interference
with assays and preserving cell densities for analysis. We recommend that future
studies of hydrogel/cell co-cultures are conducted with cell culture inserts which allow
media sharing without direct contact.
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Image analyses: Both Study 3 and Study 4 included quantitative microscopic analyses
of the interfacial region between adhered material and soft tissue. In Study 3, the
adhesive regime was defined as the area of disturbed material network juxtaposed to
the tissue surface, and was normalized by the interfacial length. Despite the
normalization, there is still a degree of judgment required to identify disturbed material
network. The methodology employed in Study 4 makes use of the linescan feature of
MetaMorph® and removes the element of judgment from the experiment; in this
approach, average bulk integrity across a predetermined distance normal to the
interface was quantified with no regard to apparent network state. Although both
methods yielded repeatable data with acceptable levels of error, the linescan feature is
both faster to execute and removes an obvious source of source of error.
Histology: A variety of histological techniques were employed throughout this work,
and along the way some adjustments to standard procedures for analyzing intact tissue-
material interfaces were devised. Firstly, prior to snap-freezing duodenal samples, it is
very helpful to fill the lumen with tissue freezing medium to preserve the tubular
morphology. Early attempts without filling the lumen result in duodenal collapse upon
freezing and destruction of the tissue-material interface. The issue of tissue staining
also required a slight modification to standard techniques, as the recommended times
for slide submersion in either xylene or ethanol were too extreme to prevent hydrogel
dissolution. For H&E stains, the usual triplicate submersions in these particular solutions
were replaced by a single submersion with no loss of tissue stain and apparent
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retention of material. We expect that future endeavors to stain tissue-hydrogel
interfaces will require similar modifications. Finally, when cryosectioning rat duodenum,
there was no tangible advantage to producing sections thinner than 20 pm; the
established benefits for analyses of arterial tissue did not seem to apply in this scenario.
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4.2 FUTURE WORK
The experimental data and design concepts resulting from this work provide both
motivation and guidance for the continued development of PEG:dextran as a clinical
adhesive. As restated throughout this thesis, an underlying goal was to promote such
advancement but do so in a manner that is readily extendable to other material
systems. We demonstrated that PEG:dextran is an advantageous probe of tissue-
material interactions, and believe further experimentation can continue to yield general
findings which are germane to a wider range of biomaterials.
For example, the incentive to design viscoelastic adhesives is readily discernible
(Study 2), but the optimal method for controlling tissue-material mechanics has not
been identified. In our work, we varied PEG:dextran bioreactive chemistry (and
consequently adhesive mechanics) through the solid content of the constituent dextran
polymer. A similar effect could be achieved by increasing the extent of dextran
oxidation, which may better preserve molecular mobility (as opposed to increasing solid
content) since network density would remain essentially constant. Alternatively, using
varied lengths of constituent polymers may also influence chain mobility after tissue-
material interfacial formation and likewise promote viscoelastic adhesion. Further
experimentation design to impart increased adhesive viscoelasticity at fixed reactive
chemistry may be a viable approach to improve PEG:dextran (or other) sealant
functional performance without reducing biocompatibility.
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We successfully established that biochemical variability among soft tissues creates
potential for tailored sealants with enhanced performance (Study 3). However, we did
not propose optimal PEG:dextran formulations for the examined tissues, which would
require a broader study of the considerable compositional design space represented by
this material system (up to six independent variables). Furthermore, we did not rate the
in vivo functional efficacy of adhesive materials at realistic implantation sites (only
subcutaneous implantations were performed). Such experimentation entails
comparatively advanced animal models and surgical techniques, but would provide a
more meaningful assessment of differential material performance and tissue response.
DOPA incorporation within PEG:dextran favorably modulated adhesion subsequent
to interfacial hydration, specifically at lower concentrations (Study 4). Comparatively
higher DOPA content within PEG:dextran both incited a negative tissue response and
reduced the sealant functional potential as assessed in an ex vivo model. These data
suggest that DOPA conjugation is a promising design strategy, but as with the tissue-
specificity study, fall short of providing optimal material formulations for specific
applications. Two immediate experimental paths emerge at the conclusion of this work:
elucidating the mechanistic basis for PEG:dextran property modulation by DOPA and
examining material performance at additional DOPA concentrations (only three
formulations tested).
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4.3 THESIS CONCLUSION
A growing understanding of the complexities and consequences of tissue-material
interactions has facilitated a steady progression of biomaterial technologies. We have
become increasingly aware that both the tissue response to a material and vice versa
must be considered for efficacious biomaterial design. Clinical sealants provide an
informative platform to study tissue-material interactions due to a functional dependence
of these implants on sustained reaction with tissue. Through analyses of adhesive
mechanics, native tissue properties, material properties, and tissue response, we have
extracted multiple design principles for creating biocompatible yet strongly adherent soft
tissue sealants. Concepts resulting from this work include the use of aldehyde-amine
chemistry to direct hydrogel adhesion to soft tissues, the functional benefits of
maintaining native tissue viscoelasticity with adhesive interactions, the potential for
design of tissue-specific sealants, and the use of biomimetic amino acid conjugation to
promote hydrogel adhesion after swell. The findings of this work reveal aspects of
tissue-material interactions which extend beyond the engineering of clinical sealants
with prospective relevance to a broader range of biomaterial implants.
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6. Appendix
Al SWELLING AND DEGRADATION
The following procedure was followed to study hydroel swelling and
degradation via gravimetric analyses:
1. Prepare dual chamber syringes with various dextran aldehyde and aminated PEG
components, with CHO:NH 2 ranging from approximately 1-10 (Table 1).
2. Cast PEG:dextran materials in disk-shaped molds (8 mm diameter, 3 mm thick).
Prepare disk samples in triplicate.
3. Extract PEG:dextran samples from molds. Measure sample dimensions with digital
calipers.
4. Weigh samples with a digital scale; denoted as dry mass.
5. Suspend each disk in an aqueous medium (100 ml MilliQTM water, 250 ml glass
beaker).
6. Weigh and measure sample dimensions at predetermined time points.
7. Record and analyze gravimetric data with Excel and Minitab softwares.
Page 163 of 189
~~-i ; l-i--- - -----i--L-i i-BL+I~F~IL:~L~ara~-r
A2 UNIAXIAL TENSILE TESTING
The following procedure was used to measure the elastic moduli of PEG:dextran
materials:
1. Prepare dual chamber syringe with specific dextran aldehyde and aminated PEG
(Table 2)
2. Cast materials with a dual chamber syringe and a 12-step mixing tip into dog-bone
molds, with extension region dimensions of: length = 10 mm, width = 8 mm, and
thickness = 6 mm.
3. Flatten top and bottom of sample with glass cover slips.
4. Allow sample to cure for 1 minute. Gently remove cover slips.
5. While sample is in the mold, add 1 ml of 1X phosphate buffered saline (PBS) to top
side. Allow PBS to absorb for 30 seconds.
6. Repeat step 5 with sample bottom side.
7. Carefully remove sample from mold.
8. Repeat steps 5 and 6 with sample out of mold.
9. Apply a displacement rate-controlled uniaxial extension to the sample with
Electroforce® mechanical tester and the following parameters:
a. Ramp displacement profile (monotonically increasing, constant rate)
b. 1.2 mm total displacement
c. Displacement rate of 0.05 mm/sec
10. Capture force/displacement data throughout entire 1.2 mm extension.
a. Transfer data to Excel file.
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b. Record and analyze uniaxial tensile data with Excel and Minitab
softwares.
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A3 ADHESION STRENGTH TESTING I
The following procedure was used to measure the adhesion strength of
PEG:dextran materials to excised intestinal tissue:
1. Prepare dual chamber syringe with the specific dextran aldehyde and aminated PEG
solutions (Table 3).
2. Sacrifice rats using carbon dioxide asphyxiation under appropriate protocol for
animal care.
3. Directly following sacrifice, harvest small intestine. Remove all waste products from
intestinal lumen.
4. Store harvested tissue in Krebs-Henseleit buffer at room temperature throughout
duration of experiment (10 hours).
5. Cut 25 mm longitudinal sections of small intestine.
6. Thread two small intestine sections with silicon tubes (2.4 mm o.d., 25 mm length).
7. Bend silicon tubes with threaded intestines, bringing sample ends together.
8. Secure one sample (in bent configuration) in each vice grip of mechanical tester.
The bent configuration promotes sample stability throughout mechanical test (Figure
12).
9. Using dual chamber syringe, polymerize 0.25 ml total volume of a test material onto
bottom intestinal sample.
10.1mmediately bring samples together such that intestinal samples are in contact
through the material, and a zero or near zero load is detected by the load cell. Allow
1 minute for material to cure and achieve adherence with tissue surfaces.
11 .Apply a constant rate displacement of 0.05 mm/sec over 4 mm total displacement.
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12.Capture force/displacement data. Record and analyze adhesion strength data with
Excel and Minitab softwares.
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A4 CYTOTOXICITY STUDIES
The following procedure was used to quantify the cytotoxic effect of PEG:dextran
degradation products on vSMC:
1. Obtain two cryovials of second passage vSMC from storage. Use standard cell
culture protocol to plate each vial onto a P10 culture plate.
2. Prepare the 8 selected PEG:dextran material formulations (Table 4). Use a silicon
mold to cast a disk (8 mm diameter, 3 mm thick) of each material variation.
3. Suspend each disk in a scintillation vial in 20 ml Dubelco's modified eagle medium
(DMEM, 1X glucose) to promote material degradation. Keep at room temperature.
4. Immediately following start of material suspension, sterilize vials (and contents) with
4 hours exposure to UV light under culture hood.
5. After cell cultures reach confluence, passage onto ten 12-well plates (1:5 passage
expansion).
6. Incubate wells until approximately 50% confluent. At this point, conduct cell counting
on well one of five selected plates.
7. At 50% confluence, replace the media in each of the wells with a 1:1 mixture of
media and material suspension supernatant (1 ml of each, 2 ml total volume per
well). In this co-culture, material degradation products have developed over a 7 day
period, and the degradation supernatant is termed the early degradation products.
8. Incubate the co-culture for 24 hours.
9. Following 24 hour incubation period, conduct cell counting and cytotoxicity assays.
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10. Repeat the above steps (1-9) again with the same materials following a 21 day
material degradation period. The degradation supernatant is now termed the late
degradation products.
11. Record and analyze cytotoxicity data with Excel software.
Cytotoxicity assay culture treatments
1. DMEM control - Cells cultured initially in normal media, but at 50% confluence
media was replaced with 50% media + 50% DMEM (for final 24 hour incubation).
2. Fully lysed - Cells cultured in normal media for the entire duration of the experiment.
Lysis buffer applied to culture prior to cytotoxicity assay in order to form the basis for
a data transform into a relative cytotoxicity.
3. Material samples - Cells cultured in normal media until 50% confluent, at which
point the normal media is replaced with (50% normal media + 50% degraded sample
supernatant) for 24 hour co-culture incubation.
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A5 PROLIFERATION STUDIES
The following procedure was used to quantify the effect of polymerized
PEG:dextran materials on fibroblast proliferation:
1. Culture 3T3 cells to approximately 50% confluence in 12-well plates.
2. Aspirate media from each well plate.
3. Add 0.25 ml (single drop from 12-step mixing tip) of a given PEG:dextran formulation
PEG:dextran to each well plate (Table 5). Follow the same material sterilization
procedure as with the cytotoxicity assay above.
4. Add 1 ml media to each well plate
5. Incubate (cells + materials) for 24 hours.
6. Following co-culture, conduct proliferation assay on all well plates.
7. Record and analyze proliferation data with Excel software.
Proliferation assay culture treatments
1. Media control - Cells cultured in normal media throughout duration of the
experiment. No PEG:dextran materials were applied to culture prior to the
conduction of the proliferation assay.
2. Material control - Proliferation assays were conducted on wells with PEG:dextran
materials but without any cells. The chemical effect of each material on the assay
reagents was examined with these controls, and was taken into account in the
interpretation of cell proliferative measurements.
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3. Material samples - Cells were grown
culture protocol until approximately
PEG:dextran was polymerized on the
cultured for 24 hours.
in 12-well plates in accordance with normal
50% confluent. At this point, 0.25 ml of
cell layer, and the cells + material were co-
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A6 BURST PRESSURE TESTING
Experimental setup for burst pressure testing
Figure 59 Duodenal tissue placement within
testing apparatus for luminal perfusion. The
wound at the center of the tissue is repaired
with various adhesive materials.
Figure 60 Repaired duodenal tissue is
housed in a chamber throughout perfusion.
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A7 LUMEN AREA DETERMINATION
Histological images for determination of duodenal lumen area
CHO:NH 2= 1 CHO:NH2 = 3 CHO:NH2= 7
Figure 61 Duodenal cross-sections prepared through cryosectioning and
staining of duodenal samples. Tissue sections were analyzed to assess the
extent of morphological disturbance (luminal compression) resulting from
sealant application and dynamic loading.
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A8 ADHESION STRENGTH TESTING II
Sample setup for testing of adhesive mechanics
The initial adheion strength testing setup(3.1.3 Materials and Methods) was replaced
by the arrangement shown below. The tissue-material-tissue interface provided by the
pictured arrangement was amenable to stress analyses because of the well defined
adhesive contact area.
Figure 62 Tissue-material-tissue interface
for adhesive mechanical testing
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A9 MORPHOLOGICAL ANALYSES OF ADHESIVE INTERFACE
Iniital definition of adhesive regime
Figure 63 The adhesive regime is defined as the region of material
discontinuity extending into the material from the tissue-material
interface.
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A10 FLUORESCENT MICROSPHERES
Fluorescent microspheres on the surface of soft tissues
Heart Lung
Figure 64 Aldehyde-coated microspheres adhere to the
surfaces of soft tissues. Microspheres are fluorescently
labeled and appear pink, while cell nuclei are stained with
DAPI and appear blue.
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All NANOINDENTATION EXPERIMENT
*The following experiment was performed in the Nanaolab at MIT under the
guidance of Dr. Krystyn Van Vliet and with a great deal of assistance from Alan
Schwartzman and Z. like Kalcioglu.
Experimental goals
DOPA conjugation enhances the sealant function of PEG:dextran after interfacial
exposure to aqueous medium. Here we measure the surface mechanics of the
unmodified PEG:dextran and 0.3% DOPA conjugate before and after swell treatments.
The metric used to analyze the materials is the elastic modulus from an adhesion test
on the MicroMaterials nanoindentation system [92]. Comparative analyses will suggest
if the observed functional enhancement is a result of intrinsic hydrogel modification
(increasing network stiffness, particularly at the surface) or is due to modulated
adhesion in an aqueous environment. If the moduli of unmodified and conjugate
samples are the same in both swell states, this data would indicate that the observed
enhancement of wet adhesion with conjugation is reflective of augmented tissue-
material interactions. Alternatively, discrepancies in mechanical data may indicate that
DOPA-modulates intrinsic material properties to confer enhanced sealant performance.
Experimental Approach
Two discs (8 mm diameter, 3 mm thickness) of each sample type (unmodified
PEG:dextran and DOPA conjugate) were prepared. Prior to testing, each disc was
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either maintained as prepared (no swell treatment) or submersed for one hour in PBS
(swell treatment). In total, four samples were analyzed:
1. Unmodified PEG:dextran, no swell treatment
2. Unmodified PEG:dextran, swell treatment
3. Conjugate, no swell treatment
4. Conjugate, swell treatment
The parameters used for the nanoindentation adhesion test were:
*1 mm radius spherical tip - a large and relatively blunt tip was selected for interaction
with this soft material.
Max load
Max depth
Initial load
Limit stop
Load rate
Dwell
Unload rate
0.2 mN
11734 nm
0.001 mN
0.01mN
0.04 mN/sec
10 sec
0.04mN/sec
The sample loading profile is depicted below (Figure 65):
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Figure 65 Sample loading profile for adhesion test on
MicroMaterials System
Experimental Data
Nanoindentation adhesion tests of each material/treatment show significant
repeatability, as evidenced by both the degree of curve overlap (Figure 66-Figure 69) and
the tabulated averages and standard deviations of the calculated elastic moduli (Table
16). Two analytical methods were used to analyze the nanoindentation data and
generate the moduli values. The Oliver-Pharr method is integrated into the
MicroMaterials software package and was readily extracted from the experimental data.
The JKR method was performed on an Excel sheet based on the following theoretical
equation derived to account for adhesion between the material and the tip:
S3(1 - ,)2 2 1
En. I -_
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The JKR method explicitly considers the increase in area under strain due to
adhesion, and as a result always produces lower values for the elastic modulus which
typically are closure to values attained by alternate methods (bulk material testing). The
largest standard deviation among all moduli was only 14 % of the mean value
(Conjugate, No Swell, Oliver-Pharr method), which can be at least partially attributed to
sample dehydration throughout testing.
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0.3 Unmodified PEG:dextran, No Swell
-4000 4000 8000 12000
- Depth (nm)
Figure 66 Adhesion test curves of unmodified PEG:dextran without swell
treatment.
-4000 4000 8000 12000
Depth (nm)
-0.2 -J
Figure 67 Adhesion test curves of DOPA-modified PEG:dextran without
swell treatment.
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Figure 68 Adhesion test curves of unmodified PEG:dextran with swell
treatment.
-4000 4000 8000 12000
1 Depth (nm)
-0.2
Figure 69 Adhesion test curves of DOPA-modified PEG:dextran with swell
treatment.
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Table 16 Calculated elastic moduli based on adhesion test
Elastic
Moduli (kPa)
No Swell
Avg
St Dev
With Swell
Avg
St Dev
Unmodified
PEG:dextran
The following constants (along with the average S for each sample) were used to
calculate EJKR:
0.5
1000000
200000
150000
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Coniuaate
Oliver-Pharr JKR Oliver-Pharr JKR
641 406 251 154
12 26 34 17
133 60 140 72
13 7 4 6
R[nm]
P[nN]
Fpo[nN]
Sample Comparisons
As expected for a material which exhibits substantial adhesion, nanoindentation data
best agreed with uniaxial tensile testing data when analyzed with the JKR method (EJKR
of 406 vs. Euniaxial of 161 kPa). The data acquired for unmodified PEG:dextran without
swell yielded an EJKR that is more than double the value measured by uniaxial tensile
testing. A possible reason for this discrepancy is an underestimation of adhesive tip-
material interactions, as the material under study is designed to be particularly sticky.
Nevertheless, the EJKR is the metric is used rather than the EOliverPharr to compare
between material/treatment variants.
The conducted experiments were designed to provide insight as to what extent the
amino acid conjugate modulated material properties in two swell states (one hour swell
vs. no swell). When comparing the unmodified PEG:dextran and conjugate samples in
the no swell state, we observed a 62% reduction (p < 0.05) in material moduli as a
result of DOPA incorporation in the network. This implies that the conjugate interferes
with network formation and results in less crosslinking, as suspected from prior
experimentation. When either the conjugate or unmodified materials were subjected to
swell treatment prior to testing, there was a substantial reduction in EJKR. However, in
the case of the unmodified material, the property reduction with hydration was much
more extreme (406 to 60 kPa) as compared to the conjugate (154 to 72 kPa).
Interestingly, the conjugate and unmodified materials had largely similar moduli (60 vs.
72 kPa) when analyzed in the swell state although the conjugate appears to have less
initial crosslinking.
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A12 SWELL RESPONSE OF DOPA CONJUGATES
The swelling behavior of the DOPA-PEG:dextran variants examined in Study 4 was
assessed in terms of dynamic swelling ratio (qd) and bulk elastic modulus (experimental
methods described in Study 1). The purpose of these additional experiments was to
provide insight into the trends in material ex-vivo performance (burst pressure)
observed throughout the course of swell treatment.
A substantial difference between unmodified PEG:dextran qd and the conjugates qd
was observed as a function of swell time, with the conjugates swelling to an essentially
equal and significantly lesser (p < 0.05) extent as compared to the unmodified
PEG:dextran (Figure 70). However, no correlation between qd and burst pressure was
found among the PEG:dextran variants throughout the observed swell time, suggesting
qd alone is not predictive of material performance in hydrated conditions.
40 -+-0 **. 0.3
30
10
0 15 30 45 60
....... ...........Swell Time (min)
Figure 70 The swell ratio (qd) of PEG:detxran-DOPA variants over the
course of 1 hour submersion in PBS. The legend number denotes the wt. %
of DOPA in the material formulation.
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The bulk elastic modulus (E) of PEG:dextran conjugates was also measured as a
function of swell time (Figure 72). The unmodified PEG:dextran experienced the most
substantial change (loss) of E with swell, while the DOPA conjugates were
comparatively stable. Once again, correlation between the elastic modulus and burst
pressure of hydrated materials was not found.
300 -, 0 ..*. 0.3
250 -A- 0.8 -X= 1.1
(U 200
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w w. eT - . .. .. .
100
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Swell Time (min)
Figure 71 The elastic modulus (E) of PEG:detxran-DOPA variants over the
course of 1 hour submersion in PBS. The legend number denotes the wt. %
of DOPA in the material formulation.
Strong linear correlation was found in a subset of the E and burst pressure data,
namely between the initial values prior to swell treatment (Figure 72). This relationship
likely emerges in the PEG:dextran system because network cohesive and functional
adhesive properties are based on analogous aldehyde-amine interactions, featuring
material-present amines in the former and tissue-present amines in the latter. Additional
correlations were found between the changes in burst pressure and modulus (Figure 73)
and the changes in burst pressure and swell ratio (Figure 74) over the entire swell
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treatment. These latter correlations demonstrate that stable material properties facilitate
maintenance of initial performance throughout material swell.
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Figure 72 Linear correlation between ex-vivo burst pressure and elastic
modulus of PEG:dextran-DOPA variants prior to swell treatment.
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Figure 73 Strong linear correlation exists between the changes in burst
pressure and modulus of PEG:dextran-DOPA variants after a 1 hour swell
treatment.
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Figure 74 Strong linear correlation exists between the changes in burst
pressure and swell ratio of PEG:dextran-DOPA variants after a 1 hour
swell treatment.
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